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ABSTRACT 
 
In horses, salmonellosis is a leading cause of life threatening colitis. Researchers 
have identified multidrug-resistant Salmonella among serotypes commonly associated 
with clinical disease in horses and humans. Few published studies have utilized whole 
genome sequencing (WGS) to evaluate Salmonella isolates from horses, though this 
approach is growing in application. Our aim was to evaluate the proportional morbidity 
attributed to phenotypic and genotypic antimicrobial resistance (AMR) patterns and 
serotypes of Salmonella from patients at an equine referral hospital in the southern 
United States.  
A total of 255 Salmonella isolates were obtained from samples submitted to a 
clinical microbiology laboratory arising in patients with diagnoses of salmonellosis that 
were admitted to the hospital between January 8, 2007 and November 4, 2015. 
Phenotypic antimicrobial resistance profiles were determined by the Sensititre® system. 
WGS was used to confirm serotypes determined according to the Kauffmann White 
scheme and to determine antimicrobial resistance genes. Sequencing libraries were 
sequenced in the Illumina MiSeq platform. Phylogenetic analyses on the main serotypes 
were performed in Parsnp and visualized using FigTree. 
 The most common serotypes were Newport (18%), Anatum (14.1%) and 
Braenderup (11.4%). The majority of the isolates were pansusceptible 219, 10 were 
resistant to less than 3 antimicrobial groups, while 25 were multi-drug resistant (>3 
antimicrobial groups). The most concerning group of resistance genes were 
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betalactamases (bla) such as blaCMY-2, blaSHV-12, blaCTX-M-27 and blaTEM-1B. The qnrB2 
and aac(6')-Ib-cr genes were present in isolates with reduced susceptibility to 
ciprofloxacin. Additionally genes encoding resistance to gentamicin (aph(3')-Ia, aac(6')-
IIc), streptomycin (strA and strB), sulfonamides (sul1), trimethoprim (dfrA), phenicol 
(catA), tetracyclines (tet(A) and tet(E)), and macrolides (ere(A)) were identified. The 
predominant replicon type was the conjugative plasmid I1 (10%) that often carries 
AmpC/ESBL betalactamases. Core-genome-based analyses revealed genetic associations 
among the strains that helped to rule in and rule out outbreaks.  
The presence of AMR Salmonella in equine patients raises the risk of 
unsuccessful treatment and concern for potential zoonotic transmission to horse owners, 
attending veterinarians and hospital staff. Understanding the epidemiology of 
Salmonella in horses admitted to referral hospitals is important for the prevention, 
control, and treatment of salmonellosis in horses.   
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Overview 
Salmonella is one of the most important foodborne pathogens in the world, 
estimated to cause 93.8 million human cases of gastroenteritis and leading to 155,000 
deaths each year (1). Salmonellosis in horses is a leading cause of life threatening colitis. 
Salmonellosis produces economic losses related to treatment costs, morbidity, and 
mortality of valued horses (2).  
 
Etiology 
Salmonella enterica, first named as Salmonella choleraesuis, was discovered by 
Theobald Smith in 1885, where his first thought was that Salmonella was the cause of 
hog cholera. Later, it was shown that hog cholera was produced by a virus and 
Salmonella was an opportunistic bacterial pathogen. Although Salmonella was 
discovered by Smith, Daniel E. Salmon (Smith’s chief), claimed credit for the discovery 
(3).  
Salmonella are part of the family Enterobacteriaceae and are classified into 
serotypes (serovars) based on the lipopolysaccharide (O), flagellar protein (H), and 
occasionally the capsular (Vi) antigens (4). Salmonellae are Gram-negative rods, non-
spore-forming, with diameters between 0.7 to 1.5μm and lengths of 2 to 5μm with a few 
exceptions, and mainly motile by flagellae. Salmonellae do not produce urease, oxidase, 
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or indole. Salmonellae are facultative anaerobic bacteria that can get energy from 
oxidation and reduction reactions using organic sources. The bacteria produce acid from 
glucose sources frequently with the production of gas (5). The Salmonella genus 
contains two species, Salmonella enterica and Salmonella bongori. Salmonella enterica 
has 6 sub-species (enterica, salamae, arizonae, diariazonae, houtonea and indica) with 
more than 2,500 identified serotypes of Salmonella enterica (6). Serotyping is performed 
by phenotypic characterization of the O and H antigens through agglutination using the 
antigenic formulae of the Salmonella serovars (7). Molecular epidemiological studies 
using high-throughput genomic technologies (Salmonella genus project: 
http://www.sanger.ac.uk/Projects/Salmonella/) are helping to refine the classifications 
based on the evolution of the previous grouped Salmonella serotypes (8).  
 
Salmonella serotypes associated with horses 
Although the trends of dominant serotypes may vary across the years, the most 
common serotypes in clinical cases in horses in United States have been reported to be: 
Typhimurium (9), Newport, Javiana and Anatum. Newport, is one of the most reported 
serotypes related to outbreaks of nosocomial Salmonella infection in horses in the 
United States (10); however, there are other serotypes reported such as Infantis (11), 
Oranienburg, Agona (12) and Typhimurium (13). A national study conducted in 1998 
(including 28 states) estimated the prevalence of fecal shedding in the equine population 
and identified 14 different serotypes, with the most frequent being Muenchen, Newport, 
Schwartzengrund and Typhimurium (14). There are host-restricted (HR) serotypes that 
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affect only one species, there are host-adapted (HA) serotypes that can cause severe 
systemic infection in various species, and there are un-restricted (UR) serotypes that can 
produce a self-limiting gastroenteritis in a broad range of species. In horses, the 
Abortusequi serovar is the only HR serotype that produces a systemic disease with the 
ability to proliferate in fetal tissues; however, the majority of the Salmonella in horses 
are UR serotypes such as Typhimurium, producing a persistent enteric colonization in 
the host, often without any major symptoms. UR serotypes have the ability to replicate 
because of their ability to adapt, while they can also develop a quick response from the 
immune system that can generate a faster clearance (15). Although HA serotypes are not 
common in horses, however the horses can become a vehicle in the distribution of these 
serotypes to other species. HA serotypes have more virulence factors and additional 
mechanisms of antimicrobial resistance that help them to survive (16).  
 
Clinical signs 
Horses with Salmonella enterica infections can exhibit a variety of clinical signs: 
from shedding bacteria in feces without apparent signs through to experiencing peracute 
death (17). Based on early experiments, there are four clinical syndromes described, as 
follows: 1) asymptomatic, 2) mild disease, 3) toxic enterocolitis, and 4) sepsis. Others 
symptoms include abortion and infectious cholangiohepatitis. Among asymptomatic 
horses, there have been two sub-categories recognized as: active carriers and silent or 
passive carriers. Active carriers are horses that exhibit fecal shedding of Salmonella. 
Passive carriers do not exhibit fecal shedding but can start to shed the bacteria after 
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surgery or other stressors (18). In mild disease, this syndrome had been described as a 
delayed onset of the disease but with rapid fecal shedding (17). Fever, depression, and 
anorexia occur within the first week followed by a short duration pf diarrhea (1-3 days). 
This syndrome has a low risk of mortality (8).  In the case of toxic enterocolitis  this is 
the typical, widely recognized clinical form of salmonellosis (19). Experimental cases 
have been characterized by fulminant diarrhea 2 or 3 days after experimental 
inoculation. Most horses start to shed the bacteria within 1-3 days after inoculation, and 
continuing to shed the bacteria if the horses remain alive (20). Horses are febrile, 
depressed, and anorexic. There is an increase in frequency of defecation and also the 
volume of feces because of high water content. Horses exhibit abdominal pain with 
increased heart rate, respiratory rate, and may exhibit injected mucous membranes. Upon 
abdominal auscultation, tympany may be heard. The horses can become bacteremic and 
laminitis is a common sequela (8). Finally, sepsis Presents in adult horses with profound 
depression. They are febrile and anorexic, and often develop ileus and gastric dilation 
(21). There is often no significant diarrhea and sometimes there is no fecal output. 
Tachycardia (80-90 beats/per min) is often present in affected animals. This syndrome 
has a high case fatality rate. Salmonella may be isolated from the liver, mesenteric 
lymph nodes and kidneys (8). Foals can present with neonatal septicemia, either with or 
without diarrhea (22, 23). Foals can also develop enterocolitis, or may develop (as 
sequelae) osteomyelitis, arthritis and omphalophlebitis. At necropsy, Salmonella can be 
isolated from multiple organs including the lungs (interstitial pneumonia) (8). Equine 
paratyphoid is caused by the host-restricted Salmonella Abortus equi, transmitted 
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primarily by the fecal-oral route and stallions can even transmit it through semen. The 
serotype remains present in the population due to subclinical carriers. This serotype has 
been not reported in recent years in United States and Europe, but has caused outbreaks 
in Japan (24). It causes abortion in mares at 7 to 8 months of gestation. Also, it has been 
associated with fistulous withers and orchitis. In foals, this serotype produces septicemia 
(8).        
 
Epidemiology  
The epidemiology of equine salmonellosis is complex. This is because a healthy 
animal can have a latent infection subsequently activated by stressful conditions such as 
overtraining, worming, early weaning, hot weather, transportation, hospitalization, or 
antimicrobial therapy, thus leading to the animal shedding Salmonella and possibly 
exhibiting clinical signs of gastrointestinal and other diseases (9). The successful spread 
and propagation of Salmonella depends on the infective dose, age of the host, immune 
response and additional conditions (25). Outbreaks usually develop in locations with 
large groups of horses such as breeding farms, racetracks, or veterinary hospitals (26). 
Salmonella shedding from horses is a potential zoonosis with public health 
consequences, because the organism has the possibility to spread to humans who are in 
direct and indirect contact with infected animals. In horses, Salmonella mortality 
depends on the animal’s age and other predisposing factors like immune system status 
and the serotype involved (18). The likelihood and magnitude of fecal shedding of 
bacteria are associated with antimicrobial treatment and stressful situations like 
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transportation, competition, general anesthesia or surgery, concurrent illness, season, 
administration of drugs, and hospitalization (27). Outbreaks of nosocomial infections 
caused by Salmonella among patients in veterinary hospitals have been well described 
(13). In veterinary medical teaching hospitals there is an additional potential economic 
hazard that results from closure or restriction of admissions, causing economic losses, 
often affecting the reputation of hospitals, and interrupting educational and clinical 
activities (10). 
 
Risk factors at hospitals 
Several studies were aimed at trying to identify exposure factors that can 
influence policies to prevent and control Salmonella transmission in the hospital 
environment (8). In two studies of hospitalized horses, it was found that the odds of 
nosocomial Salmonella Saintpaul infection were higher in patients with colic, receiving 
parental antimicrobials and in horses intubated with nasogastric tubes (28, 29). 
Abdominal surgery has been identified as a risk factor for nosocomial Salmonella 
infection in horses (30). Animals treated with antimicrobials before surgery may be at 
higher risk for salmonellosis or Salmonella shedding. One hypothesis is that the normal 
intestinal flora competes with Salmonella in its ecological niche and treatment with 
antimicrobial drugs may disrupt these complex bacterial population dynamics. Another 
hypothesis is that surgical stress may generate severe alterations of host-defense 
mechanism in horses (30). One study reported that foals with gastrointestinal disease 
more readily shed Salmonella during hospitalization (31). There are 4 possible 
 7 
 
explanations: 1) foals are more susceptible to colonization with Salmonella after 
parturition due to the lack of microflora (32), 2) foals are immune-incompetent, 
depending on maternal immunoglobulins to generate protection against the bacteria (33), 
3) after foaling the infected mares can become asymptomatic shedders and infect the 
foals (23), and 4) coprophagia is common, especially in foals between 1 to 2 months 
after birth (34).     
 
Pathogenesis  
The main mode of transmission of Salmonella is via the fecal-oral route; rarely, 
airborne transmission has also been recognized (35). Non-specific and specific host 
defenses are in place to mitigate infection of Salmonella. Following ingestion, the 
majority of the bacteria die because the organism cannot survive the gastric environment 
and salivary bactericidal enzymes. However, if sufficient bacteria arrive in the stomach 
(≥108), some of the organisms can survive and will reach the small intestine and colon. 
Other barriers to Salmonella infection, found in the gut include: intestinal proteases, 
lysozymes, antimicrobial peptides, bile salts, complement and phagocytes, as well as the 
other bacteria that comprise the gut microbiome (36). In the gut, Salmonella adhere to 
the microfold (M) cells. This is the first target of the bacteria since there is a lack of 
physical barrier (e.g., glycocalyx and mucus); however, later they can invade other cells 
like goblet cells and enterocytes (37). Entrance into the host cells allows the pathogen to 
evade host defenses and invade target tissues. Fimbriae are pattern-recognition receptors 
that activate signaling pathways in macrophages by binding on the cell surface or within 
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the phagosome (38). Virulence and host interactions are possible due the presence of 
particular proteins encoded by genes found in the large clusters on the bacterial 
chromosome on pathogenicity islands (SPI). Salmonella have 16 pathogenicity islands 
distributed among the different species, subspecies and serotypes, each encoding 
different virulence factors needed for different phases of pathogenesis. However, almost 
all Salmonella contain the following common five pathogenicity island: SPI 1 necessary 
for bacterial invasion of the intestinal epithelial cells (intestinal phase), SPI 2, 3, and 4 
required for bacterial growth and survival inside the host cells (systemic phase), and SPI 
5 products that mediate intestinal inflammation and fluid secretion. There are additional 
genes that are extrachromosomal on plasmids and can promote bacterial growth, 
prolonged survival in the host and antimicrobial resistance (39).  
 
Detection of Salmonella  
The diagnosis of salmonellosis is made via appropriate clinical findings; 
however, asymptomatic cases may occur. Confirmation by laboratory culture through 
isolation of the organism from a clinical specimen is required (40). Isolation of the 
bacterium is the most commonly used confirmative test to detect the presence of 
Salmonella. When used, bacterial isolation is a highly sensitive diagnostic method via 
the use of selective enrichment and selective plating agar (41). Serial bacterial cultures 
are recommended to decrease the possibility of failing to detect Salmonella in patients 
by shedding low concentrations of organisms, or intermittently (17). Further 
characterization of the Salmonella causing disease typically includes serotyping and 
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antimicrobial susceptibility testing. This characterization helps to establish the 
appropriate treatment regimen and improves the ongoing surveillance of the organism 
(8). PCR detection is faster than bacterial isolation and may provide rapid results, which 
helps to implement earlier infection control measures; however, this technique has the 
potential for misclassification (false positives) of horses classified negative after 7 serial 
samples (8). The specificity and sensitivity of the real-time PCR increases if the target 
gene is the spaQ (42) or invA (43). In this new era, ‘omics’ technologies like whole 
genome sequencing (WGS) are useful to make available a fast, cost-effective, and high 
throughput method that substitutes for many phenotypic and genotypic assays and 
provides an enormous set of analyzable data (44).  
 
Antimicrobial use and antimicrobial resistance  
The most common antimicrobials used to treat salmonellosis in horses are 
ceftiofur, enrofloxacin, and gentamicin (45, 46). However, the use of antimicrobials to 
treat Salmonella is controversial because such treatments may favor the persistence of 
the organism in the intestines following recovery. Additionally, the intestinal protective 
flora is affected by broad-spectrum antimicrobials; as such, their use may increase the 
selection of antimicrobial-resistance associated with commensal bacteria (45) and may 
contribute to overgrowth of undesirable toxigenic bacteria such as Clostridium difficile 
(47).  
Antimicrobial resistance (AMR) is a great challenge for animal and human 
health, and while there are several studies exploring this area in horses, there remains a 
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great necessity to more carefully evaluate the temporal trends and associations of 
antimicrobial resistance among Salmonella serotypes in horses in order to identify 
strategies to prevent infection and control outbreaks in the hospital environment. In a 
recent retrospective study in United States, Salmonella from equine specimens submitted 
to a diagnostic center were found to be more resistant to ceftiofur and gentamicin than to 
enrofloxacin (48). Isolates from sick horses submitted to the National Veterinary Service 
Laboratories (NVSL) tended to have increased resistance year after year to beta-lactams, 
phenicols, aminoglycosides, sulfisoxazoles, tetracyclines and quinolones (49). 
Furthermore, some serotypes tend to harbor more resistance genes than others, as was 
the case of an MDR Salmonella Newport (8 antimicrobials) that harbored and expressed 
an ESBL gene (blaSHV-12) identified in an outbreak in a large animal hospital with many 
patients affected and with high case fatality (50).  Although there are many studies that 
focus on outbreaks caused by Salmonella in horses, there are few studies that study the 
trends of resistance to antimicrobials of Salmonella isolated from equine teaching 
veterinary hospitals, thus further taking into account the additional risks to public health.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 
Antimicrobial resistance in Salmonella     
Successful treatment is aided by rapid diagnosis and the ability to choose an 
effective antimicrobial for patients with invasive Salmonella infections. Recently, 
evaluation of antimicrobial resistance in bacteria isolated from horses has started to 
receive increased attention; however, until now the studies have often been focused on 
methicillin-resistant Staphylococcus aureus. Clinically significant resistance is now 
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being reported in Gram-negative members of the Enterobacteriaceae family (51). 
Salmonella is recognized as an important carrier of genes encoding for antimicrobial 
resistance and easily can transfer its resistance by plasmids to other resident E. coli (52).    
The antimicrobial classes each have different modes of action that disrupt the 
normal functioning of the bacteria. The main modes of actions are: disruption of cell 
wall synthesis, inhibition of DNA/RNA synthesis, inhibition of protein synthesis, or 
interference with another important metabolic pathway (53). Bacteria can acquire 
resistance to an antimicrobial via a chromosomal mutation, inductive expression of a 
latent chromosomal gene or by exchange of genetic material (Figure 1). The main 
antimicrobial resistant mechanisms are classified in three categories: 1) alteration of the 
target site, 2) exclusion of the antimicrobial from the cell (reducing permeability or 
through efflux pumps), and 3) production of antimicrobial inactivating enzymes (54).  
 
 
Figure 1. Antimicrobial resistance in bacteria. Material adapted from Tadvi, 2012 (55). 
 
 
Vertical 
Horizontal 
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Chloramphenicol is a broad spectrum antimicrobial that inhibits the microbial 
protein synthesis specifically joining to the 50S subunit at the ribosome (56). Enzymatic 
inactivation by CATs enzymes is a well know mechanism but also there are other 
resistance mechanisms reported; for example, permeability barriers (loss of porins) (57), 
phosphotransferases inactivation, target site with mutations, and efflux pumps systems 
(58). CATs can inactivate chloramphenicol, thiamphenicol and azidamfenicol; however, 
florfenicol is not inactivated due to a different chemical structure. The A-1 
chloramphenicol acetyl transferase (A-1 CAT) add 2 acetyl groups to the antimicrobial 
causing its inactivation (56).  
All the antibiotics of the Beta-lactam family have a beta-lactam nucleus in their 
structure. Penicillins and derivatives, beta-lactam inhibitors, cephalosporins, 
carbapenems and monobactams are part of this antimicrobial family (59). The 
mechanism of action is by binding to the penicillin-binding proteins (PBPs) and inhibit 
the cell wall production in the bacteria interfering with the linking of peptidoglycans and 
stopping terminal transpeptidation. In general, the enzymes that hydrolyze the beta-
lactam family are classified based in their activity into: 1) narrow conferring resistance 
only to penicillins and cephalosporins), 2) moderate, 3) broad and 4) ESBLs (Extended 
Spectrum Beta-lactamases) conferring resistance to penicillins, cephalosporins of first, 
second and third generation, aztreonam, but not to carbapenems and they are inhibited 
by inhibitors (60).  
Ampicillin (and amoxicillin) inhibits the enzymes that synthesize pedtidoglycan 
and inducing autolytic enzymes associated to the membrane. Ampicillin resistance is by 
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beta-lactamases such as TEM-1 and SHV-1, though these enzymes are inhibited by the 
synergistic activities of clavulanic acid (61).  
Cephalosporins and cephamycins can inhibit the bacterial cell wall synthesis 
similarly as penicillin (59). The cephalosporins are classified by generations based on 
general features of the antimicrobial action (62). First generation (cephalotin and 
cefazolin) with modest activity against gram negative bacteria; these cephalosporins are 
inhibited by TEM and AmpC enzymes (63). Second generation (cefoxitin, cefotetan, and 
cefmetazole) have better activity against gram negative, but less than third generation. 
Third generation (cefotaxime, ceftazidime, ceftiofur and cefoperazone) are less active 
against gram positive instead they are very active against Enterobacteriaceae. The CTX 
enzyme can hydrolyze cefotaxime, and they are inhibited effectively in its following 
order, first by tazobactam, second by clavulanate and third by sulbactam. Fourth 
generation (cefepime) have a broad expectrum of activity compared with third 
generation and is more stable against hydrolysis mediated by plasmid and chromosomal 
beta-lactamases (59). The continued selective pressure to these antimicrobials resulted in 
selection of plasmids that carried mutants of the enzymes TEM and SHV, becoming 
responsible of the hydrolysis of third and sometimes fourth generation cephalosporins 
(64). High levels of resistance to extended-spectrum cephalosporins is mainly due to 
extended spectrum beta-lactamases (ESBLs) encoded by blaCTX-M-15 and blaSHV-12 genes 
and also by plasmid mediated AmpC beta-lactamase enzymes as CMY, DHA, ACC-1 
(65). 
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The mode of action of trimethoprim and sulfamethoxazole is by inhibition of 
phases in the folate metabolism and inhibition of the DNA synthesis. Modification of 
targets by dihydrofolate reductase and dihydropteroate synthase respectively produce 
resistance to trimethoprim and sulfamethoxazole (56).  
Fluoroquinolones (FQ), like ciprofloxacin, have become the first–line drug to 
treat Salmonella in adult humans. However, treatment failures have been associated with 
reduced susceptibility to ciprofloxacin (0.125-1 ug/mL) in some bacteria (66). Nalidixic 
acid resistance is an early indicator of ciprofloxacin resistance. The increase in the use of 
ciprofloxacin has led to increased resistance to it (65). Quinolone resistance-determining 
region (QRDR) mutations in the A subunit of DNA gyrase and presence of plasmid-
mediated quinolone resistance genes qnr and aac(6’)-lb-cr develop quinolone resistance 
in the bacteria. Presence of mutations in many genes, reduced membrane permeability, 
active efflux pump, and/or presence of qnr genes are associated with high level 
resistance to ciprofloxacin (67).   
The increase in fluoroquinolone resistance and the contraindication for use of 
ciprofloxacin in children due to its effects on cartilage development has led to increased 
use of third-generation cephalosporins like ceftriaxone. Fluoroquinolone and ESBL 
resistance remains a main problem in the effective treatment of bacterial infections in 
both human and animals (68).   
Aminoglycosides are broad spectrum antimicrobials, their mechanism of action 
is by inhibition of protein synthesis disintegrating the bacterial cell membranes (69). 
There are different recognized mechanisms of resistance to aminoglycosides as follows: 
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1) Active efflux (70), 2) Decreased permeability (71), 3) Change in the ribosome (72) 
and 4) The most common by aminoglycoside-modifying enzymes that inactivate the 
aminoglycosides (73).  
Tetracyclines are antimicrobials with broad spectrum, relative safe, with low 
cost, becoming the second antimicrobial in use after penicillin (60). Different modes of 
action for tetracycline are described. The first mode described was the interaction with 
the ribosomes and blocking protein synthesis (74). Later was discover that some 
tetracycline derivatives are not good interacting with the ribosomes, instead of that, the 
interaction is with the bacterial membrane (75). Tetracycline resistance mechanism are 
three: 1) efflux pumps reliant on energy, 2) ribosomal protection proteins and 3) or 
enzymatic inactivation. In gram negative bacteria tet(A), tet(B), tet(C), tet(D), tet(E), 
tet(G), tet(H), tet(I), tet(J), tet(Y), tet(30) and tet(31) genes are recognized as exclusive 
(76).  
 
Plasmids in Salmonella  
Bacteria carry extra-chromosomal self-replicating genetic elements called 
plasmids. The most frequent serotypes associated with infections in humans and farm 
animals commonly harbor plasmids. Some serotypes have specific virulence plasmids. 
Salmonella often also harbor additional plasmids that encode resistance to 
antimicrobials, and still other plasmids with unknown function (77, 78).  
The plasmids can be classified by 1) functionality as virulence, antimicrobial 
resistance or unknown function; or classified by 2) incompatibility groups accordingly to 
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their bacterial replication and maintenance (79). IncI, producing I pili; IncN, N3-related; 
IncF, producing F pili; and IncP, RP4-related plasmids among others (78). At this time, 
27 different Inc groups among Enterobacteriaceae are recognized by the plasmid section 
of the National Collection of Type Cultures including – very importantly for Salmonella 
– IncF (FII to FVII) and IncI (I1, Iγ, I2) (80). Although PCR-based replicon typing 
(PBRT) can be used to detect the replicons of the majority of plasmid families in 
Enterobacteriaceae, this scheme has some limitations because the grouping is built only 
on plasmids from the old recognized Inc groups and could not identify novel replicons. 
A more accurate approach is to characterize the replicon according to its full length 
sequence; as of late 2017, more than 800 plasmids have been identified. Currently, more 
than 100 resistance plasmids have been typed and classified accordingly to their specific 
families (80).       
The majority of the plasmids are conjugative, conferring resistance to different 
antimicrobials. The most common location of the antimicrobial resistance genes is 
within transposons that can be transfer from plasmids to chromosome and from 
chromosome to plasmid (77). While plasmids are most important for the storage and 
spread of genetic information, they can also carry integrons as is the case of IncF and 
IncL/M plasmids that carried Class 1 integrons (81). Antimicrobial resistance is 
routinely shared among a complementary group of conjugative plasmids, transposons 
and integrons. New cassettes can be incorporated by the integron to transfer by a 
conjugative plasmid to a host bacterium, and thereafter can be integrated into the host 
chromosome by transposition (77). The very important and clinically relevant 
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association between resistance plasmids and virulence genes has been previously 
described (81).   
In summary, although Salmonella can produce severe disease in horses, 
relatively few serotypes of Salmonella are capable of producing clinical disease. 
Treatment for Salmonella is currently limited to antimicrobials like beta-lactams, 
quinolones and gentamicin. Recent studies demonstrate incremental increases in the 
resistance of Salmonella to additional antimicrobials which impedes the effective 
treatment of salmonellosis and other important diseases, both in horses and in humans. 
 This research was performed to estimate the diversity of Salmonella isolated 
from patients at an equine referral hospital in the southern United States. The objective 
was to contribute further to developing a better understanding of the causative strains 
associated with clinical salmonellosis, its transmission and its association with 
antimicrobial resistance. 
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CHAPTER II  
MATERIALS AND METHODS 
 
Evaluation of the proportional morbidity attributed to each Salmonella enterica 
serotype 
 
Sample set and isolates  
The sample set included 255 Salmonella strains derived from the first clinical 
sample collected and submitted to the clinical microbiology laboratory from any patient 
admitted to the veterinary medical teaching hospital with a differential diagnosis of 
salmonellosis between January 8, 2007 and November 4, 2015. Samples were initially 
inoculated into tetrathionate broth and incubated overnight at 37°C prior to DNA 
extraction – or else culture on XLT-4 and MacConkey agar. Prior to 2010, samples were 
only subjected to culture; after 2010, patient samples were first tested by PCR to spaQ 
gene which encode for the surface presentation of antigens protein SpaQ 
(transmembrane) (82) and then cultured if positive by PCR. Tetrathionate broths that 
tested positive by direct PCR were subsequently streaked onto XLT-4 and MacConkey 
agar. Hydrogen sulfide producing colonies from XLT-4 and lactose negative colonies 
from MacConkey agar were subcultured to trypticase soy agar supplemented with 5% 
sheep blood and grown overnight at 37°C. Isolates were then tested for oxidase 
production. Oxidase negative isolates were then presumptively identified as Salmonella 
based on production of characteristic biochemical reactions when grown on triple sugar 
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iron agar (TSI), lysine iron agar (LIA), Christensen’s urea agar, tryptophan broth and 
agglutination with polyvalent antisera. These isolates were sent to the National 
Veterinary Services Laboratory (NSVL) in Ames, Iowa for serotyping according to the 
White-Kauffmann-Le Minor scheme. Some isolates were preserved in skim milk at 10% 
and others in cryopreservation beads at -80°C for further analysis.  
 
DNA extraction for whole genome sequencing (WGS) 
In the present study, Salmonella DNA from stored isolates was extracted using 
the QIAamp 96 DNA QIAcube HT Kit ™ (Qiagen, Valencia, CA) in the QIAcube HT 
™ instrument. One Salmonella colony per isolate from a fresh culture was suspended 
into 5 ml of Trypticase Soy Broth (Difco, Becton Dickinson, Franklin Lakes, NJ) and 
incubated overnight at 37°C. From the overnight culture, 1 ml was pipetted into a 1.2 ml 
micro-collection tube and centrifuged at 4,000 rpm for 15 minutes at room temperature. 
The supernatant was removed and the pellet was re-suspended in a mixture of ATL 
buffer and DX reagent. One tube of small pathogen lysis beads was combined with the 
suspension to break the cells using the Qiagen TissueLyser system ™ (Qiagen, Valencia, 
CA) at 25 Hz, for 5 minutes. The tubes were briefly centrifuged and 40 µl of Proteinase 
K was added to each tube. The tubes were incubated at 56°C for 1 hour at 900 rpm in the 
ThermoMixer ™ (Eppendorf, Hauppauge, NY) and then a heat shock was done for 10 
minutes at 95°C. The suspension was cooled at room temperature and 4 µl of RNAse A 
was added to the suspension. The samples were placed on the QIAcube HT for DNA 
extraction using the program Gram- QCHT Salmonella & E. coli Microtube (woAL). 
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DNA quality was measured by 260/280 absorbance ratio on the Omega Fluostar 
microplate reader (BMG LABTECH, Cary, NC). DNA quantity was measured with a 
Quant-iT™ Pico Green® ds DNA Assay kit (ThermoFisher Scientific) and the DNA 
was stored at -20C until further use. 
 
Whole genome sequencing using the Illumina MiSeq™ 
Whole-genome sequencing (WGS) was performed using the Illumina MiSeq™ 
platform (Illumina, San Diego, CA) to determine serotypes and plasmid replicons of the 
Salmonella strains. Libraries for 32 Salmonella DNA samples were multiplexed using 
the Illumina Nextera XT kit following the manufacturer instructions using the 
Qiagility™ robot (Qiagen, Valencia, CA) to set up the reactions and the thermocycler 
(Eppendorf) for amplification. The quality and quantity of the libraries were checked on 
the Fragment Analyzer™ instrument (Advanced Analytical, Ankeny, IA, USA). The 
libraries were run on the Miseq (automated DNA sequencer) using the MiSeq Reagent 
Kit v3 (Illumina, San Diego, CA) with paired-end 2 x 300 base pairs reads. A 
comprehensive work flow of the library preparation is showed in Figure 2. 
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Figure 2. Nextera XT DNA library preparation workflow 
 
 
Bioinformatics analysis of WGS data 
Raw sequence data (fastq files for reverse and forward ends) were obtained from 
the Illumina MiSeq runs and used for further analysis after the sequencing run was 
complete. De novo genome assembly was performed by the Velvet software package 
using SRST2 (a short read sequence typing pipeline) (83) on the Illumina BaseSpace™ 
platform, by Spades software package using PATRIC (Pathosystems Resource 
Integration Center) (84) and by CGE (Center for Genomic Epidemiology) website (85).  
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Serotype analysis 
The SeqSero pipeline was used for serotype identification (86). On the web-
based tool, raw sequence reads derived from the Illumina MiSeq were uploaded. The 
somatic (O) group was determined by analysis of wzx and wzy genes and by analysis of 
the rfb cluster; meanwhile, flagellar (H) phases were determined by analysis of fliC and 
fljB genes combined in the same H antigen database. Mapping was run 3 times for the 
final serotype call. 
 
Validation of serotypes through serotyping using the White-Kauffmann-Le Minor scheme 
and WGS 
All Salmonella were previously sent to the National Veterinary Services 
Laboratories (NSVL) and serotyped using the White-Kauffmann-Le Minor scheme; 
those results were compared with the results obtained by the SeqSero pipeline and any 
notable differences and potential biases explored.    
 
Plasmid analysis  
Genomes were analyzed through SRST2 on the Illumina Basespace platform 
using the PlasmidFinder database (87) for the determination of plasmid types. In 
addition, PlasmidFinder from the database of the Center for Genomic Epidemiology 
(CGE) (88) was used to perform additional comparative analyses.  
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Statistical Analysis 
The epidemiological unit for analysis was the isolate (individual serotype) 
recovered from the first sample per patient admission to the hospital. Information from 
each isolate was recovered from the database of the clinical laboratory and hospital 
database and saved as a spreadsheet in Excel format. The data were imported to 
STATA® software version 14.0 (StataCorp, College Station, TX) and were used to 
create variables to perform descriptive analyses (including graphics such as bar and pie 
charts, and statistics such as proportional prevalence and 95% confidence intervals). 
Determination of the association (odds ratios) between the clinical signs of salmonellosis 
and the main serotypes were evaluated using likelihood-based chi-square or Fisher exact 
tests. 
 
Evaluation of antimicrobial resistance patterns of Salmonella isolated from horses 
admitted to an equine referral hospital in the southern United States 
 
Antimicrobial susceptibility testing  
The determination of the antimicrobial susceptibility of Salmonella was performed using 
the broth microdilution method via the Sensititre® system (TREK, Thermo Scientific 
Microbiology, Oakwood Village, OH) to identify the MIC (Minimum Inhibitory 
Concentration). This test was performed using the National Antimicrobial Resistance 
Monitoring System (NARMS) custom plate CMV3AGNF that has 14 antimicrobials 
among 9 classes of antimicrobials (Table 1). 
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 The guidelines of surveillance from NARMS were followed to generate 
comparable data procedures and interpretations with representative antimicrobial 
families as beta-lactam including ampicillin, amoxicillin/clavulanic acid, cefoxitin, 
ceftiofur and ceftriaxone; quinolones such as nalidixic acid and ciprofloxacin; folic acid 
inhibitors like sulfisoxazole and trimethoprim/sulfamethoxazole; aminoglycosides like 
streptomycin and gentamicin were part of the observation. Lastly, azithromycin, 
chloramphenicol and tetracycline also were evaluated. The Sensititre® system is a 
simple, practical and quantitative method that measures the MIC and provides clinical 
interpretative criteria (resistant, intermediate or susceptible) based on the Clinical 
Laboratory Standards Institute (CLSI) breakpoints (89).  
The isolates were streaked onto Trypticase Soy Agar (TSA) with 5% sheep blood 
agar and incubated at 37 °C for 18 hours. The colonies were suspended in 4 ml of 
sterilized water and adjusted to 0.5 McFarland standard. 50 µl of the culture suspension 
was transferred into 11 ml of Mueller-Hinton broth and 50 µl of suspension was 
inoculated onto the plates using the Sensititre® Automated Inoculation Delivery System 
(TREK). Plates were incubated at 37 °C for 18 hours, then read on Sensititre 
OptiRead™ instrument (TREK, Thermo Scientific Microbiology, Oakwood Village, 
OH). The results were processed in the SWIN software (TREK, Thermo Scientific 
Microbiology) and were interpreted accordingly to CLSI (89). Intermediate isolates were 
reclassified as susceptible for the purpose of epidemiological analysis. Isolates resistant 
to three or more classes of antimicrobials were considered multidrug-resistant (MDR). 
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Controls  
Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Pseudomonas 
aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, and Enterococcus 
faecalis ATCC 29212 (American Type Culture Collection, Manassas, VA) were used as 
quality control (QC) strains for susceptibility testing. During each laboratory processing 
run, the QC strains were run with each new batch of plates, or during an extended break 
in processing. 
 
Table 1. Minimum Inhibitory Concentration range used in the sensititre CMV3AGNF 
plate. 
 
Antimicrobial Abbreviation Range Breakpoint 
Ampicillin  AMP 1 - 32 ≥ 32 
Amoxicillin/Clavulanic Acid  AUG2 1/0.5 - 32/16 ≥ 32 / 16 
Azithromycin  AZI 0.12 - 16 ≥ 32 
Cefoxitin  FOX 0.5 - 32 ≥ 32 
Ceftiofur  XNL 0.12 - 8 ≥ 8 
Ceftriaxone  AXO 0.25 - 64 ≥ 4 
Chloramphenicol  CHL 2 - 32 ≥ 32 
Ciprofloxacin  CIP 0.015 - 4 ≥ 1 
Gentamicin  GEN 0.25 - 16 ≥ 16 
Nalidixic Acid  NAL 0.5 - 32 ≥ 32 
Streptomycin  STR 2 - 64 ≥ 64 
Sulfisoxazole  FIS 16 - 256 ≥ 512 
Tetracycline TET 4 - 32 ≥ 16 
Trimethoprim/Sulphamethoxazole  SXT 0.12/2.4 - 4/76 ≥ 4 / 76 
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Bioinformatics analysis of WGS data 
Resistance genes 
The genomes were analyzed for presence of AMR genes through the ResFinder 
tool using the SRST2 application in the Illumina BaseSpace platform and via the Center 
for Genomic Epidemiology webpage (88). 
Statistical analysis 
The data were imported into STATA® software version 14.0 (StataCorp., 
College Station, TX) in Trek SWIN (csv) format. Intermediate resistance was collapsed 
into susceptible when binary encoded resistance was portrayed. The presence or absence 
of a known antimicrobial resistance gene or genes was compared with the interpretation 
of resistant or susceptible to a given corresponding antimicrobial. Measure of agreement 
between the phenotypic and genotypic results was made using kappa analysis (90).   
 
Distribution of temporally clustered cases of the major Salmonella serotypes throughout 
the years 
The distribution of cases was analyzed according to the main Salmonella 
serotypes by the day of admission of the patient by each year in order to identify 
temporal clusters of cases that can suggest potential outbreaks and detect possible 
nosocomial transmission.  
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Phylogenetic analysis 
 In this study, phylogenetic analysis was conducted in three of the most common 
serotypes that presented temporal clusters of cases according to the admission date of the 
patient to the hospital (Salmonella Anatum, Salmonella Braenderup, and Salmonella 
Newport) to explore the epidemiology of possible outbreaks or potential circulating 
strains at the hospital.  
Assembled genomes (contigs) from the Salmonella genome of the three main 
serotypes were used to construct the massive core-genome alignments into Parsnp in 
the Harvest package (91). Parsnp is useful in intraspecific genome analysis (outbreaks 
analysis). The phylogenetic tree was visualized with FigTree (92).  
Phylogenetic trees were created and analyzed by each major serotype along with 
a complete genome reference and subsequently with the information available per case 
(year of admission, antimicrobial pattern, presenting complaint, age of the patient, and 
farm location). 
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CHAPTER III  
RESULTS  
 
Evaluation of the proportional morbidity attributed to each Salmonella enterica 
serotype 
The 255 Salmonella strains isolated between January 8, 2007 and November 4, 
2015 were analyzed and 98.4 % were isolated from fecal samples and 1.6 % (4) were 
isolated from blood.  
 
Breeds 
The most common horse breed among the 30 different breeds admitted to the 
hospital with a differential diagnosis of salmonellosis was Quarter Horse 51.8% (132), 
followed by Thoroughbred 9.4% (24), American Paint 7.4% (19), and then Arabian 
6.7% (17) (Figure 3).  
 
Age 
The mean age of the horses based on 233 records was 7 years with a range of 
newborn through 24 years (Figure 4). Horses were classified into 4 groups – according 
to age – for further analysis, as follows: a) Foals (less than 1 year), b) Juvenile (1 - 2 
years), c) Adult (greater than 2 years, less than 20 years) and d) Seniors (greater than or 
equal to 20 years).
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Figure 3. Number of cases for each horse breed admitted to the hospital with differential diagnosis of salmonellosis. 
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Figure 4. Percentage of cases (out of 233) for each age category of horse admitted to the 
hospital with a differential diagnosis of salmonellosis. 
 
 
Complaints 
The most common complaints in horses were colic 47.4 % (121), followed by 
diarrhea 21.6 % (55), and then other general symptoms 20.4% (52) such as fever, 
dehydration, weight loss or anorexia. Some of the cases came directly from necropsy 2.8 
% (7) that were either dead on arrival or else were euthanized (Figure 5). The complaints 
were grouped according to the system affected for further analysis (Figure 6). 
.    
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Figure 5. Percentage of the most common complaints in horses admitted to the hospital 
with a differential diagnosis of salmonellosis between January 8, 2007 and November 4, 
2015. 
 
 
 
 
Figure 6. Percentage of presenting clinical complaints classified by affected system in 
horses admitted to the hospital with a differential diagnosis of salmonellosis between 
January 8, 2007 and November 4, 2015. 
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Associations between age and clinical complaint 
From the horses positive to Salmonella admitted to the hospital, the odds of fever 
complaint were significantly (P = 0.033) higher (8.6 times as high) in juvenile horses, 
compared with the odds of horses from other age (Odds ratio = 8.6; 95% CI = 0, 44.6). 
Upon looking at associations with more specific symptoms we found that the odds of 
diarrhea complaint were significantly (P < 0.0001) higher (4.5 times as high) in foals 
compared with the odds of older horses (Odds ratio = 4.5; 95% CI = 2.32, 8.76). The 
odds of colic complaint were significantly (P < 0.0001) higher (7.29 times as high) in 
adults compared with the odds of horses in other age (Odds ratio = 7.29; 95% CI = 3.66, 
14.48). The odds of musculoskeletal complaint were significantly (P = 0.0001) higher 
(9.41 times as high) in foals compared with the odds of older horses (Odds ratio = 9.41; 
95% CI = 2.59, 33.93). No statistically significant associations were found between 
urinary and respiratory complaints and horse age groups. 
 
Associations between breed and clinical complaint 
From the horses positive to Salmonella admitted to the hospital, the odds of colic 
complaint were significantly (P = 0.0017) higher (3.38 times as high) in American Paint 
breed compared with the odds of other breeds (Odds ratio = 3.38; 95% CI = 1.22, 9.29). 
The odds of respiratory signs were significantly (P < 0.0001) higher (23.14 times as 
high) in mixed breed compared with the odds of other breeds (Odds ratio =23.14; 95% 
CI = 4.01, 139.3). 
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Serotypes   
Among 255 Salmonella isolates, 46 different serotypes were identified by the 
White-Kauffmann-Le Minor scheme and SeqSero; while, 4% (10 strains) did not match 
when comparing both techniques. Due that in –silico serotyping platforms are based in 
the antigenic gene carried but not necessarily expressed by the isolate (93), for the ten 
problematic strains it was used the most confident result gave it by White-Kauffmann-Le 
Minor scheme. The most common serotype recovered was Newport 18 % (46), followed 
by Anatum 14% (37), Braenderup 11.4% (29), Infantis 7.8 % (20), Javiana 5.5% (14), 
Typhimurium 5.5% (14), Rubislaw 5.1% (13) and Montevideo 2.4% (6), the remaining 
percentage (30.3%) was comprised of 38 additional serotypes (Table 2).  
Table 2. Frequency of Salmonella serotypes in horses admitted to the hospital with a 
differential diagnosis of salmonellosis between January 8, 2007 and November 4, 2015. 
 
Serotype Frequency Percent (%) 
111_51:g,z51:- 1 0.39 
4,12:i:- 3 1.18 
6,7:-:e,n,z 1 0.39 
6,7:k:- 1 0.39 
Agona 4 1.57 
Altona 1 0.39 
Anatum 37 14.51 
Bareilly 1 0.39 
Bovismorbificans 1 0.39 
Braenderup 29 11.37 
Carrau 1 0.39 
Cerro 4 1.57 
Freetown 2 0.78 
Fresno 1 0.39 
Gaminara 3 1.18 
Give 4 1.57 
Havana 2 0.78 
Hvittingfoss 2 0.78 
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Table 2. Continued 
 
Serotype Frequency Percent (%) 
Infantis 20 7.84 
Javiana 14 5.49 
Kentucky 3 1.18 
Kiambu 2 0.78 
Manhattan 1 0.39 
Mbandaka 3 1.18 
Meleagridis 2 0.78 
Minnesota 1 0.39 
Mississippi 2 0.78 
Montevideo 6 2.35 
Muenchen 2 0.78 
Muenster 3 1.18 
Newport 46 18.04 
Norwich 1 0.39 
Oranienburg 4 1.57 
Paratyphi 2 0.78 
RoughO:b:1,5: 1 0.39 
RoughO:gms: 1 0.39 
Rubislaw 13 5.1 
Ruiru 1 0.39 
Saintpaul 2 0.78 
Senftenberg 1 0.39 
Tennessee 1 0.39 
Thompson 3 1.18 
Typhimurium 14 5.49 
Typhimurium Var 5 1.96 
Untypeable 1 0.39 
Weslaco 2 0.78 
Total 255 100 
 
 
Associations between serotype and clinical complaint 
From the horses positive to Salmonella admitted to the hospital, the odds of 
subclinical presence of salmonellosis were not significantly (P = 0.058) higher (3.61 
times as high) in S. Braenderup compared with the odds of other serotypes (Odds ratio = 
3.61; 95% CI = 1.22, 9.29). The odds of digestive (complaints affecting the digestive 
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system) were significantly (P = 0.013) lower (0.27 times) in S. Typhimurium compared 
with the odds of other serotypes (Odds ratio = 0.27; 95% CI = 0.09, 0.78), meaning that 
other serotypes had 3.7 times the odds of digestive complaints as S. Typhimurium. The 
odds of the signs associated with musculoskeletal system were significantly (P = 0.0015) 
higher (13.37 times as high) in S. Typhimurium compared with the odds of other 
serotypes (Odds ratio = 13.37; 95% CI = 3.59, 50.76). The odds of respiratory system 
signs were not significantly (P = 0.2318) higher (4.96 times as high) in S. Rubislaw 
compared with the odds of other serotypes (Odds ratio = 4.96; 95% CI = 0, 36.71). None 
of the serotypes were statistically significantly associated with urinary, nervous system 
or general complaints. 
 
Association between serotype and age of horse 
From the horses positive to Salmonella admitted to the hospital, the odds of 
serotype S. Braenderup presence were significantly (P = 0.0014) higher (3.94 times as 
high) in foals compared with the older horses (Odds ratio = 3.94; 95% CI = 1.59, 7.71). 
The odds of serotype S. Typhimurium presence were significantly (P = 0.0014) higher 
(5.58 times as high) in foals compared with the older horses (Odds ratio = 5.58; 95% 
CI= 1.83, 16.98). 
 
Temporal trends of serotypes 
The frequency of detection of the main serotypes varied across the years (Figure 
7).  Salmonella Anatum, S. Braenderup and S. Newport, were the most common 
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serotypes throughout the years of the study; however, the cases of S. Newport and S. 
Braenderup decreased in 2015 while S. Anatum increased during the same year. 
Salmonella Javiana was present at a low frequency throughout the years, similar to S. 
Infantis, although the latter was entirely absent in 2013. Salmonella Typhimurium was 
present at a low frequency in most of the years, increasing in 2008, but absent again in 
2011 and 2014. Salmonella Rubislaw was present in most of the years in low frequency 
but with 3 cases in 2009 and 2012. Of the top 8 serotypes by frequency, Salmonella 
Montevideo had the lowest frequency and it was not present in the years 2010 and 2014. 
38 additional serotypes not represented in Figure 7 were also present through the years 
of the study but at a lower frequency.      
   
 
Figure 7. Frequency of detection of the main serotypes throughout the years of the study 
(2007-2015) 
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Distribution of temporally clustered cases of the major Salmonella serotypes throughout 
the years 
There was no cluster of serotypes in 2007; however, S. Braenderup was highly 
prevalent in the first part of the 2008 year (8 closest cases between March and June) with 
1 further case on the 3rd of November. Meanwhile, S. Newport was highly prevalent in 
the second part of the same year with 10 closely clustered cases between July and 
December (Figure 8).  
 
 
 
Figure 8. Salmonella Braenderup and Salmonella Newport case sequences by admission 
date in 2008.  
 
S. Braenderup was present with a maximum of 5 cases during two dates in 
February of 2009. Salmonella Anatum also was present with its 2 closest cases in April 
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and July. Salmonella Infantis was present in May, September and October (with its 3 
closest cases) (Figure 9).  
 
 
 
Figure 9. Salmonella Braenderup case sequences per admission date in 2009.  
 
In 2010, S. Braenderup was present in April and May with 3 close cases, 
followed by 2 additional cases on October 11th 2010. During 2011, S. Infantis presented 
3 close cases in November, while S. Newport was present with 2 cases occurring within 
September and October. In 2012, S. Newport was the serotype that presented as an 
apparent temporal cluster with 2 close cases in September, 3 cases in October, and 2 
cases between November and December. From the 8 major serotypes found in the study, 
S. Newport was the most common in 2013 with three close cases occurring in September 
(out of 7 cases in the year). In 2014, S. Newport was present between 26 and 109 days 
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after New Year (3 cases). In 2015, S. Anatum was present between April and May (6 
cases) and 1 case occurred in August (Figure 10).   
 
 
 
Figure 10. Salmonella Anatum case sequences per admission date in 2015.  
 
 
Plasmid analysis 
Fifteen different replicon types were identified (A/C2, COL, FIA, FIB, FII, FIIS, 
HIR, HI2, I1, I2, Q, R, U, X, and Y); meanwhile, the predominant type was I1 at ~10% 
present in 25 isolates out of the total (Figure 11). Out of 255 isolates, 96 (38%) of the 
Salmonella isolates where identified as harboring at least one plasmid. 
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Figure 11. Number of detected replicons in Salmonella from horses admitted to the 
hospital with differential diagnosis of salmonellosis between January 8, 2007 and 
November 4, 2015. 
   
 
Presence of plasmids between the serotypes  
The highest prevalence of plasmids was detected in Salmonella Anatum (31/21), 
S. Typhimurium (20/10), S. Newport (14/10), S, Braenderup (12/10), S. Rubislaw (9/7), 
S. Javiana (9/8), S. Agona (8/4) and S. Typhimurium var 5 (7/3) (Figure 12). 
Interestingly, the most prevalent replicon type in S. Anatum was I1 (11) among 10 
different replicon types that were found (Figure 13). The most prevalent replicon types 
in S. Typhimurium were FIB (9) and FIIS (9), among 4 different replicon types (Figure 
14). The most common replicon types in S. Newport were COL (3) and FII (3) among 9 
different replicon types (Figure 15). The most prevalent replicon types in S. Braenderup 
were I1 (6), and Y (4) among 4 different replicon types (Figure 16).      
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Figure 12. Number of detected plasmid replicon types in the different Salmonella serotypes.  
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Figure 13. Number of detected plasmid replicon types in Salmonella Anatum. 
 
 
 
Figure 14. Number of detected plasmid replicon types in Salmonella Typhimurium. 
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Figure 15. Number of detected plasmid replicon types in Salmonella Newport. 
 
 
 
Figure 16. Number of detected plasmid replicon types in Salmonella Braenderup. 
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Evaluation of antimicrobial resistance patterns of isolated Salmonella from horses 
admitted to an equine referral hospital in the southern United States 
 
Antimicrobial resistance patterns  
The minimum inhibitory concentration (MIC) was determined for each of 255 
Salmonella strains across all antimicrobials in the NARMS Gram-negative panel. The 
proportion of tested isolates that were resistant to any individual antimicrobial ranged 
from a low of 0% (ciprofloxacin) to a high of 10.2% (sulfisoxazole). Out of 255 strains, 
219 (85.9%) were pan-pansusceptible (i.e., susceptible to all the antimicrobials), 10 (3.9 
%) were resistant to less than 3 groups of antimicrobials and 26 (10.2%) were classified 
as multidrug resistant - MDR (resistant to 3 or more classes of antimicrobials). Among 
isolates exhibiting resistance to at least one antimicrobial, a total of 20 distinct patterns 
of antimicrobial resistance was found among 14 different serotypes. S. Anatum 
presented 8 different patterns of resistance with 5 being MDR strains, followed by 
Rubislaw (3 MDR), Braenderup (2 MDR strains) and Newport (1 MDR) (Table 3). 
 
 Out of 255 strains, 19 (7.4 %) of the Salmonella did not harbor any AMR genes, 
while 236 (92.5 %) carried at least a single gene. A ‘heat map’ of serotype and plasmid 
replicon types among 36 antimicrobial-resistant Salmonella isolates are illustrated in 
Figure 17. 
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Table 3. Resistance patterns for the Salmonella strains isolated from equine samples 
submitted to the clinical microbiology laboratory between January 8, 2007, and 
November 4, 2015 that were tested for susceptibility to 14 antimicrobials.  
 
Resistance pattern Serotype 
% (no.) of 
resistant isolates 
AMP-XNL-AXO-CHL-GEN-STR-FIS-TET-SXT 
 
 
4,12:i:- 
Anatum 
Rubislaw 
33 (1/3)a 
3 (1/37) 
15 (2/13) 
AMP-AXO-CHL-GEN-NAL-STR-FIS-TET-SXT Anatum 3 (1/37) 
AMP-AZI-XNL-AXO-CHL-GEN-STR-FIS-TET-SXT Agona 100 (4/4) 
AMP-AZI-GEN-NAL-STR-FIS-TET-SXT Anatum 3 (1/37) 
AMP-AZI-GEN-NAL-TET-SXT Anatum 3 (1/37) 
AMP-CHL-GEN-STR-FIS-TET-SXT Newport 2 (1/46) 
AMP-CHL-GEN-FIS-TET Anatum 3 (1/37) 
AMP-XNL-AXO-GEN-STR-FIS-TET-SXT Rubislaw 8 (1/13) 
AMP-XNL-AXO Braenderup 3 (1/29) 
AUG2-AMP-FOX-XNL-AXO-CHL-GEN-STR-FIS-TET 
Kiambu 
Oranienburg 
50 (1/2) 
25 (1/4) 
AUG2-AMP-FOX-XNL-AXO-CHL-STR-FIS-TET 
Braenderup 
Typhimurium 
3 (1/29) 
7 (1/14) 
AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT 
 
Braenderup 
Rubislaw 
14 (4/29) 
8 (1/13) 
FIS-TET-SXT Infantis 5 (1/20) 
STR-FIS-TET Muenster 33 (1/3) 
STR-FIS Newport 2 (1/46) 
FIS Newport 2 (1/46) 
GEN Anatum 3 (1/37) 
STR 
Anatum 
Kentucky 
3 (1/37) 
33 (1/3) 
TET 
Anatum 
Kentucky 
Montevideo 
5 (2/37) 
33 (1/3) 
17 (1/6) 
 
aNumber of Salmonella exhibiting a resistance pattern /Total number of Salmonella per 
serotype  
None of the isolates were resistant to ciprofloxacin. AUG2 = amoxicillin/clavulanic acid 
2:1 ratio, AMP = ampicillin, AZI = azithromycin, AXO = ceftriaxone, CHL = 
chloramphenicol, CIP = ciprofloxacin, FIS = sulfisoxazole, FOX = cefoxitin, GEN = 
gentamicin, NAL = nalidixic acid, SXT = trimethoprim/sulfamethoxazole, STR = 
streptomycin, TET = tetracycline and XNL = ceftiofur.   
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Figure 17. Heat map summary of serotypes, antimicrobial resistance phenotypes and AMR genotypes, among 36 
Salmonella isolates exhibiting resistance to at least one antimicrobial. Also included are the corresponding Inc plasmid type 
(s). Blue and white squares denote the presence and absence of a specific feature, respectively. AUG2 = amoxicillin/clavulanic 
acid 2:1 ratio, AMP = ampicillin, AZI = azithromycin, AXO = ceftriaxone, CHL = chloramphenicol, CIP = ciprofloxacin, FIS 
= sulfisoxazole, FOX = cefoxitin, GEN = gentamicin, NAL = nalidixic acid, SXT = trimethoprim/sulfamethoxazole, STR = 
streptomycin, TET = tetracycline and XNL = ceftiofur.   
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Antimicrobial resistance genes  
A total of 38 different resistance genes were identified and most of them were 
associated with clinical resistance with a few associated with decreased susceptibility to 
at least one of the 14 tested antimicrobials.  
 
Beta-lactamase resistance genes  
A total of four different genes encoding beta-lactamase enzymes were identified. 
Out of 255 strains, blaTEM-1B (encoding resistance to aminopenicillins and 1
st generation 
cephalosporins) was found in 5% of Salmonella isolates, blaSHV-12  (an extended-
spectrum betalactamase ESBL of significant concern encoding resistance to third and 
fourth generation cephalosporins) was found in 4%, blaCMY-2 (a AmpC cephamycinase 
encoding resistance to second and third generation cephalosporins) was found in 4%, 
and blaCTX-M-27 (another ESBL gene of great concern) was found in 0.4% (Figure 18). 
Among the serotypes, the cephamycinase blaCMY-2 gene was detected mainly in S. 
Braenderup, whereas blaSHV-12 and blaTEM -1B were detected mainly among other 
serotypes like S. Agona and Rubislaw (Figure 19). 
 48 
 
 
 
Figure 18. Proportion of beta-lactamase genes detected in the Salmonella from patients 
at an equine referral hospital 
 
 
 
 
Figure 19. Beta-lactamase genes detected in the main serotypes of strains of Salmonella 
from patients at an equine referral hospital. The numbers inside of the bars show the 
identification of the strains. 
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Quinolone resistance genes 
Out of 255 strains, 2 different genes encoding quinolone resistance were 
identified aac(6’)-lb-cr (3%) and qnrB2 (2%) (Figure 20). For the latter, the resistance 
phenotype is typically that of reduced susceptibility, but below the breakpoint MIC value 
established for clinical resistance. Among the serotypes, the aac(6’)-lb-cr gene was 
detected mainly in S. Rubislaw and Agona, whereas the qnrB2 was detected also among 
S. Rubislaw isolates (Figure 21).  
 
 
Figure 20. Relative proportion of quinolone genes (sums to 100%) detected in 
Salmonella from patients at an equine referral hospital in the southern United States. 
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Figure 21. Quinolone genes detected among the main serotypes of Salmonella isolated 
from patients at an equine referral hospital in the southern United States. The numbers 
inside of the bars show the identification of the strains. 
 
 
Aminoglycoside resistance genes 
Although the most common aminoglycosides genes were aac(6’)-Iaa and 
aac(6’)-Iy, these genes did not appear to confer phenotypic resistance to 
aminoglycosides or any other class of antimicrobial. Out of 255 strains, the most 
common aminoglycoside resistance genes from 15 different genes detected were strA 
(7.1%), strB (7.5%) both encoding streptomycin resistance and aac6-IIc (4.4%) 
encoding gentamicin resistance (Figure 22). Among the serotypes, the aac(3’)-IId gene 
encoding gentamicin resistance was detected only in S. Anatum, aac(3’)-VIa encoding 
gentamicin resistance was detected in both S. Kiambu and S. Oranienburg, aac(6’)-IIc 
was detected mainly in S. Rubislaw, S. Agona and S. Anatum, aacA4 encoding 
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tobramycin and amikacin and kanamycin resistance was detected mainly in S. Agona, 
aadA1 encoding streptomycin resistance was detected in S. Muenster, aadA2 also 
encoding streptomycin resistance was detected mainly in S. Rubislaw and S. Anatum, 
aadA7 encoding streptomycin resistance was detected only in S. Typhimurium, aph(3’)-
la encoding gentamicin resistance was detected mainly in S. Agona,  aph(3’)-lc encoding 
gentamicin resistance was detected in S. Anatum and S. Rubislaw, rmtE encoding 
gentamicin resistance was detected only in S. Braenderup, strA was detected mainly in S. 
Rubislaw and Agona, and strB gen and  was detected also in S. Rubislaw (Figure 23).  
 
 
 
Figure 22. Relative proportion of aminoglycoside genes (sums to 100%) detected in 
Salmonella from patients at an equine referral hospital in the southern United States. 
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Figure 23. Aminoglycoside genes detected among the main serotypes of strains of Salmonella from patients at an equine 
referral hospital. Numeric coding within each bar represent case numbers. The numbers inside of the bars show the 
identification of the strains. 
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Sulfonamide resistance genes 
 Out of 255 strains, the sul gene was found with two different variations encoding 
for sulfonamide resistance (sul1 (8%) and sul2 (5%)) (Figure 24).  
Among the serotypes, the sul1 gene was detected mainly in S. Braenderup and the sul2 
was mainly detected among S. Rubislaw (Figure 25).  
 
 
 
 
Figure 24. Relative proportion of sulphonamide genes (sums to 100%) detected in 
Salmonella from patients at an equine referral hospital in the southern United States.  
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Figure 25. Sulfonamide genes detected among the main serotypes of strains of 
Salmonella from patients at an equine referral hospital in the southern United States. The 
numbers inside of the bars show the identification of the strains. 
 
 
Folate pathway inhibitor resistance genes 
Among trimethoprim / sulfamethoxazole resistant strains, a single gene family 
with four variants encoding for trimethoprim resistance were identified as dfrA18 
(3.9%), dfrA15 (1.9%), dfrA12 (0.4%) and dfrA14 (0.4%) (Figure 26). Among the 
serotypes, dfrA18 and dfrA15 alleles were detected mainly in S. Agona, dfrA14 in S. 
Infantis and dfrA12 in S. Anatum (Figure 27).  
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Figure 26. Relative proportion of folate pathway inhibitors alleles (sums to 100%) 
detected in Salmonella from patients at an equine referral hospital in the southern United 
States.  
 
 
Figure 27. Folate pathway inhibitors genes detected in the main serotypes of strains of 
Salmonella from patients at an equine referral hospital in the southern United States. The 
numbers inside of the bars show the identification of the strains. 
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Phenicol resistance genes  
Out of 255 strains, 3 different genes encoding phenicol resistance were identified 
as catA2 (4.1%), floR (2.0%) and cmlA1 (2.0%) (Figure 28). Among the serotypes, 
catA2 and cmlA1 were detected mainly in Agona while floR was detected among a 
variety of different serotypes (Figure 29). 
 
 
 
Figure 28. Relative proportion of amphenicol genes (sums to 100%) detected in 
Salmonella from patients at an equine referral hospital in the southern United States.  
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Figure 29. Amphenicol genes detected in the main serotypes of strains of Salmonella 
from patients at an equine referral hospital in the southern United States. The numbers 
inside of the bars show the identification of the strains. 
 
Tetracycline resistance genes 
 Out of 255 strains, 5 different tetracycline resistance genes were identified as 
follows: tet(A) (1.9%), tet(B) (2.4%), tet(C) (0.4%), tet(D) (1.6%) and tet(E) (2.4%) 
(Figure 30). Among the serotypes, tet(A) was detected in multiple serotypes, tet(B) was 
detected mainly in S. Anatum tet(C) was detected only in S. Kentucky, tet(D) was 
detected in S. Rubislaw and S. Anatum, and tet(E) was detected mainly in S. Agona 
(Figure 31).  
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Figure 30. Relative proportion of tetracycline genes (sums to 100%) detected in 
Salmonella from patients at an equine referral hospital in the southern United States. 
 
 
 
Figure 31. Tetracycline genes detected in the main serotypes of strains of Salmonella 
from patients at an equine referral hospital in the southern United States. The numbers 
inside of the bars show the identification of the strains. 
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Macrolide resistance genes 
Out of 255 strains, 2 different genes encoding macrolide resistance were 
identified as ere(A) (3.9%) encoding for erythromycin and mphA (2.8%) encoding for 
azithromycin (Figure 32).Among the serotypes, ere(A) and mphA were mainly detected 
among S. Agona (Figure 33). 
 
 
 
Figure 32. Proportion of macrolide genes detected in Salmonella from patients at an 
equine referral hospital in the southern United States. 
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Figure 33. Macrolide genes detected in the main serotypes of strains of Salmonella from 
patients at an equine referral hospital in the southern United States. The numbers inside 
of the bars show the identification of the strains. 
 
Other resistance genes 
Among ansamycin resistant strains, 2 different alleles encoding ansamycin 
resistance were identified as arr-3 (0.8%) and arr-6 (1.2%) encoding for rifampin 
(Figure 34). Among the serotypes, arr-3 and arr-6 were mainly detected among S. 
Agona (Figure 35). 
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Figure 34. Proportion of ansamycin alleles detected in Salmonella from patients at an 
equine referral hospital in the southern United States. 
 
 
Figure 35. Ansamycin alleles detected in the main serotypes of strains of Salmonella 
from patients at an equine referral hospital in the southern United States. The numbers 
inside of the bars show the identification of the strains. 
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Agreement between detected AMR genes and MICs values 
The agreement between presence of AMR genes identified by the ResFinder tool 
and the resistance phenotype by Sensititre system are shown in Table 4. 
Aminoglycosides, beta-lactams, cephems, penicillins, folate pathway inhibitors, 
phenicols and macrolides had substantial agreement (Kappa = 0.61-0.94) when 
comparing phenotypic and genotypic results. Tetracyclines presented good agreement 
(Kappa = 0.76), and when considering the intermediate MIC of ciprofloxacin, it 
presented moderate agreement (Kappa=0.48) with the presence of quinolone resistance 
genes (encoding reduced susceptibility, but not clinical resistance). Nalidixic acid had 
very poor agreement (Kappa=-0.02) when comparing the phenotypic resistance and the 
presence of quinolone genes. 
 
Phylogenetic analysis 
A whole-genome single nucleotide polymorphism (SNP)-based tree was 
constructed using Parsnp 1.2 and visualized with FigTree. The analysis was conducted 
only with the most frequent serotypes (Salmonella Anatum, Braenderup and Newport) 
with presence of clusters between the days of admission of the patients to the hospital in 
the years of the study to investigate a possible genetic association between the isolates 
that may be indicative of an outbreak in the hospital.  
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Table 4. Genotype and phenotype comparison of 255 Salmonella strains obtain from equine samples submitted to the clinical 
lab between January 8, 2007, and November 4, 2015 
 
Antimicrobial agent  
No. of test results 
Agreement Kappa 
 Resistant phenotype Susceptible phenotype 
Genotype: 
resistant 
Genotype: 
susceptible 
Genotype: 
resistant 
Genotype: 
susceptible 
Aminoglycoside             
Gentamicin 18 4 3 230 97.25 0.8222 
Streptomycin 17 4 2 232 97.65 0.8373 
Beta-lactam/beta-lactam inhibitor             
Amoxicillin/clavulanic acid  9 1 0 245 99.61 0.9453 
Cephems             
Cefoxitin  9 1 0 245 99.61 0.9453 
Ceftiofur   19 1 3 232 98.43 0.8962 
Ceftriaxone 19 1 3 232 98.43 0.8962 
Penicillin             
Ampicillin 22 3 0 230 98.82 0.9297 
Folate pathway inhibitor             
Sulfisoxazole 22 5 1 227 97.65 0.8670 
Trimethoprim/sulfamethoxazole 13 6 0 236 97.65 0.8004 
Macrolide             
Azithromycin  5 1 2 246 98.43 0.7064 
Phenicol             
Chloramphenicol  14 2 1 238 98.82 0.8970 
Quinolone             
Ciprofloxacin* 4 2 6 249 96.86 0.4848 
Nalidixic Acid* 0 3 10 242 94.9 -0.0184 
Tetracycline             
Tetracycline 18 7 3 227 96.08 0.7612 
* Analysis using MIC (minimum inhibitory concentration) classified for reduced susceptibility
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Salmonella Anatum  
We analyzed 37 genomes; however, the phylogenetic tree was constructed with a subset 
of 31 genomes (Figure 36). Measurement of the maximal unique exact matches shared 
by two sequences by the MUM index >0.01 were excluded  from the analysis (91). 
The complete genome of Salmonella enterica subsp. enterica serotype Anatum strain 
USDA-ARS-USMARC-1765 (NZ_CP014659.2) was used as a reference to assemble the 
phylogenetic tree; this strain is from a human salmonellosis case and was part of a study 
that compared the genomes of Salmonella Anatum arising from human and bovine 
sources (94). There were 2 main clusters: Cluster (I) and Cluster (II), with two cases 
from 2014 grouped outside of the two main clusters. Cluster (I) could be further sub-
divided into four sub-clusters (I-a to I-d). Sub-cluster I-a contained 3 cases from 2008, 
2011 and 2012. Two of the 3 cases were adult horses and one was a foal; all presented 
with colic. Interestingly, in both cases from adults S. Anatum were pan-susceptible, 
while the foal case was MDR (AMP-CHL-GEN-FIS-TET) detected by annotation genes 
in the PATRIC platform. Sub-cluster I-b contained 2 cases from two adults with a 
presenting complaint of colic and the Salmonella was pansusceptible in both cases. Sub-
cluster I-c contained 6 cases and grouped with the reference strain; 3 isolates were from 
adult horses, one from a juvenile, one from a foal and other without reported age; 3 cases 
had a complaint of colic and one horse was euthanized; 2 isolates were MDR and 4 
isolates were pansusceptible. Sub-cluster I-d contained 5 cases from April and May of 
2015 and all the horses were adults; however, the complaints were different; one case 
was presented with colic and two cases presented with a dental complaint. Two isolates  
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Figure 36. Whole-genome SNP-based phylogenetic tree of 33 Salmonella Anatum and a Salmonella Anatum reference strain 
generated by Parsnp and visualized by FigTree. The branch lengths are expressed in terms of changes per number of SNPs. 
The numbers in color show the bootstrap corresponding to the specific internal node. Strain names are marked with the colors 
red (reference), blue (MDR), green (resistant) and black (susceptible). Strain names are labeled with the year of admission of 
the patient to the hospital. Clusters are colored according to the phylogenetic group (clade). Cluster I includes: Sub-cluster I-a 
(pink), I-b (blue), I-c (purple) and I-d (green). Cluster II includes: Sub-cluster II-a (yellow) and II-b (red). The scale bar shows 
the estimated number of substitutions per SNP.
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had tetracycline resistance; while the others strains were pansusceptible.    
Cluster II contained 2 sub-clusters (II-a, and II-b). Cluster II-a (6 cases) were 
from 2007, 2008, 2009, 2010, 2014 and 2015. Four cases were adult horses, one was a 
foal and one was without reported age. Four cases were presented as colic and two had 
diarrhea. All the strains were pan-susceptible. Cluster II-b (6 cases) from 2008, 2009 and 
2013 included four adults and two foals. Most of the strains were pan-susceptible; 
however, one was gentamicin resistant. Detailed information concerning the cases per 
each cluster is shown in Table 5.  
 
Salmonella Braenderup 
A phylogenetic tree was constructed using data from 27 sequenced S. Braenderup 
(Figure 37). The complete genome of S. Braenderup Sal_JBP_2011K-0222 from the 
United States Centers for Disease Control and Prevention (CDC) was obtained through 
personal communication with Dr. Henk den Bakker from the University of Georgia; this 
was used as a reference to analyze the phylogenetic tree.  
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Table 5. Equine cases of genetically related Salmonella Anatum from Cluster I and II by phylogeny. 
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I I-a 09-038 Mixed Breed 11/29/2008 12/3/2008 Adult colic Pansusceptible
I I-a 10-053 Hanoverian 2/17/2011 2/28/2011 Adult colic Pansusceptible
I I-a 11-033 Quarter Horse 5/15/2012 5/24/2012 Foal colic AMP-CHL-GEN-FIS-TET
I I-b 09-077 Quarter Horse 4/12/2009 4/15/2009 Adult colic Pansusceptible
I I-b 11-064 Quarter Horse 12/17/2012 12/19/2012 Adult colic Pansusceptible
I I-c 08-061 Quarter Horse 2/1/2008 2/4/2008 Adult colic AMP-AZI-GEN-NAL-STR-FIS-TET-SXT
I I-c 08-062 Arabian 2/28/2008 2/28/2008 Foal general signs Pansusceptible
I I-c 09-005 Shire 5/23/2008 5/28/2008 Adult colic AMP-AZI-GEN-NAL-TET-SXT
I I-c 10-005 Quarter Horse 11/5/2009 11/7/2009 Adult colic Pansusceptible
I I-c 10-095 American Paint 10/15/2011 10/24/2011 Juvenile diarrhea, fever Pansusceptible
I I-c 11-046 Thoroughbred 10/1/2012 10/1/2012 NR euthanasia Pansusceptible
I I-d 12-093 Quarter Horse 5/3/2015 5/7/2015 Adult lethargic, down, fever TET
I I-d 12-094 Quarter Horse 5/6/2015 5/10/2015 Adult colic Pansusceptible
I I-d 12-095 Quarter Horse 5/5/2015 5/17/2015 Adult epistaxis TET
I I-d 13-008 Mixed Breed 4/16/2015 4/16/2015 Adult dental Pansusceptible
I I-d 13-009 Mixed Breed 4/16/2015 4/16/2015 Adult dental Pansusceptible
II II-a 08-036 Quarter Horse 9/27/2007 10/1/2007 NR colic, dehydrated, colitis, diarrhea Pansusceptible
II II-a 09-003 Foreign Warm Blood 5/27/2008 6/2/2008 Foal colic Pansusceptible
II II-a 09-048 Quarter Horse 2/8/2009 3/18/2009 Adult colic Pansusceptible
II II-a 12-056 Appaloosa 9/9/2014 9/10/2014 Adult colic Pansusceptible
II II-a 12-099 Quarter Horse 5/19/2015 5/23/2015 Adult diarrhea Pansusceptible
II II-a 10-028 Thoroughbred 8/25/2010 8/28/2010 Adult dehydration Pansusceptible
II II-b 08-076 Irish Sport Horse 4/13/2008 5/14/2008 Foal fetlock arthroscopy Pansusceptible
II II-b 09-078 Quarter Horse 4/16/2009 4/29/2009 Foal diarrhea Pansusceptible
II II-b 09-089 Quarter Horse 7/21/2009 7/21/2009 Adult colic Pansusceptible
II II-b 09-091 Quarter Horse 7/9/2009 9/13/2009 Adult general signs Pansusceptible
II II-b 11-082 Arabian 7/8/2013 7/24/2013 Adult colitis Pansusceptible
II II-b 11-093 Quarter Horse 9/16/2013 9/30/2013 Adult colic GEN
A mino glyco sides B eta- lactams
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inhibito r 
T etracycline
 68 
 
There were 2 main clusters: Cluster (I) and Cluster (II). Cluster (I) contained 
strains from 2007 to 2015 and could be further sub-divided into five sub-clusters (I-a to 
I-e). Sub-cluster I–a contained 6 cases from 2009, four foals presented with diarrhea and 
two adults were boarding without signs; the strains had the same pan-susceptible pattern 
and these cases where coming from a known outbreak on the same ranch. Sub-cluster I–
b contained two cases in foals, and one in adult – the adult was boarding. The strain from 
one foal had the ESBL gene blaCTX-M-27.  Sub-cluster I–c contained one case in an adult 
and one in a foal. Sub-cluster I–d was formed by three cases in adults presenting with 
colic. Sub-cluster I-e contained 5 cases from 2008, four with the same antimicrobial 
resistance pattern (AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT) and with the same 
presence of antimicrobial resistance genes (rmtE, blaCMY-2 and sul1), suggesting that it 
was a clonal group; however, the single isolate from Case 08-056 was pan-susceptible 
and had 4 nucleotide substitutions per site more than the multi-drug resistant strains. 
Cluster (II) contained 6 cases from 2007 (1 case), 2008 (2 cases) and 2009 (3 cases). 
Three adults and three foals; two with diarrhea, two with colic, one dystocia and one 
surgery.  Detailed information of the cases per each cluster is shown in Table 6.  
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Figure 37. Whole-genome SNP-based phylogenetic tree of 27 Salmonella Braenderup and a Salmonella Braenderup reference 
strain generated by Parsnp and visualized using FigTree. The branch lengths are expressed in terms of changes per number of 
SNPs. The numbers in color show the bootstrap corresponding to the specific internal node. Strain names are marked with the 
colors red (reference), blue (resistant) and black (susceptible). Strains names are labeled with the year of admission of the 
patient to the hospital. Clusters are colored according to the phylogenetic group (clade). Cluster I includes: Sub-cluster I-a 
(cyan blue), I-b (purple), I-c (pink), I-d (yellow) and I-e is (green). Clade II (light violet). The scale bar shows the estimated 
number of substitutions per SNP. 
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Table 6. Equine cases of genetically related Salmonella Braenderup from Cluster I and II by phylogeny. 
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I I-b 08-023 Dutch Warmblood 6/26/2007 7/12/2007 Foal lameness Pansusceptible
I I-e 08-049 Thoroughbred 4/10/2008 4/11/2008 Adult respiratory - poss. strangles AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT
I I-e 08-052 Irish Draught 3/28/2008 4/16/2008 Juvenile colic AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT
I I-e 08-056 Quarter Horse 3/18/2008 3/20/2008 Foal diarrhea Pansusceptible
I I-e 08-065 Quarter Horse 3/20/2008 3/27/2008 Foal diarrhea AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT
I I-e 08-072 Quarter Horse 3/18/2008 3/22/2008 Foal bloody and watery diarrhea AUG2-AMP-FOX-XNL-AXO-GEN-FIS-SXT
I I-a 09-049 Thoroughbred 2/24/2009 2/28/2009 Foal diarrhea Pansusceptible
I I-a 09-051 Thoroughbred 2/22/2009 3/23/2009 Foal diarrhea, lethargic, dehydration Pansusceptible
I I-a 09-052 Thoroughbred 2/24/2009 3/9/2009 Foal diarrhea Pansusceptible
I I-a 09-054 Thoroughbred 2/22/2009 3/23/2009 Adult boarding Pansusceptible
I I-a 09-055 Thoroughbred 2/24/2009 3/1/2009 Adult boarding Pansusceptible
I I-a 09-073 Thoroughbred 3/24/2009 4/6/2009 Foal watery diarrhea, dehydration Pansusceptible
I I-c 09-092 Quarter Horse 7/28/2009 8/5/2009 Adult colic Pansusceptible
I I-d 10-021 American Paint 4/18/2010 4/24/2010 Adult colic Pansusceptible
I I-d 10-022 Quarter Horse 5/14/2010 5/25/2010 Adult colic Pansusceptible
I I-c 10-024 Quarter Horse 5/29/2010 6/3/2010 Foal diarrhea Pansusceptible
I I-b 10-030 Gypsy Vanner 10/11/2010 10/25/2010 Adult boarding Pansusceptible
I I-b 10-032 Gypsy Vanner 10/11/2010 10/25/2010 Foal salmonellosis AMP-XNL-AXO
I I-d 11-090 Gypsy Vanner 9/11/2013 9/11/2013 Adult colic Pansusceptible
II 08-003 Arabian 1/8/2007 1/24/2007 Adult colic Pansusceptible
II 09-004 Dutch Warmblood 5/23/2008 5/29/2008 Foal watery diarrhea, fever, not eating Pansusceptible
II 09-010 Foreign Warm Blood 6/6/2008 6/6/2008 Foal surgery Pansusceptible
II 09-030 Quarter Horse 11/3/2008 11/8/2008 Adult colic Pansusceptible
II 09-046 Quarter Horse 1/31/2009 2/25/2009 Foal diarrhea Pansusceptible
II 09-068 Quarter Horse 3/21/2009 3/22/2009 Adult dystocia, possible ruptured rectum Pansusceptible
A mino glyco sides B eta- lactams
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Salmonella Newport  
The S. Newport phylogenetic analysis used 48 genomes; however, the final 
phylogenetic tree included only 42 genomes (Figure 38). Genomes with MUMi distance 
>0.01 were excluded from the analysis. The complete genome of Salmonella enterica 
subsp. enterica serotype Newport strain 0007-33 (accession number: NZ_CP013685.1) 
was used as a reference to analyze the phylogenetic tree; this strain is from a bovine 
gastroenteritis case collected by University of Pennsylvania Salmonella Reference 
Center (95). There were 2 main clusters: Cluster I with 2 subclusters and Cluster II with 
6 subclusters. Subcluster I-a contained 2 strains from 2 adult horses from 2011 and 2012. 
Subcluster I-b contained 8 cases from different years, including three adults, two foals, 
one senior horse and two with ages not reported; four had signs of colic, one with colitis, 
one with diarrhea and one foal that was lame in its front legs.  Cluster (II) contained 6 
sub-clusters. Sub-cluster II-a included two cases: one adult, and one without age 
reported; the first case was presenting with diarrhea and weight loss, while the other 
presented with fever and problems in the lungs. Sub-cluster II-b contained two cases: 
one foal with colic and one adult with possible choke.
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Figure 38. Whole-genome SNP-based phylogenetic tree of 42 Salmonella Newport and Salmonella Newport reference strain 
generated by Parsnp. The branch lengths are expressed in terms of changes per number of SNPs. The tree was visualized using 
FigTree. Reference strain is marked with color red, blue stars (MDR) and black (susceptible). Strain names are labeled with the 
year of admission of the patient to the hospital. Clusters are colored according to the phylogenetic group (clade). Cluster I 
includes: Sub-cluster I-a (yellow) and I-b (cyan blue). Cluster II includes: Sub-cluster II-a (gray), II-b (rose), II-c (light green), 
II-d (emerald green), II-e (blue) and II-f (pink). The scale bar shows the estimated number of substitutions per SNP. 
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In Sub-cluster II-c both cases had colic. Sub-cluster II-d contained 7 cases, 6 
were adults, 5 presented with colic (one of these with presence of stomach ulcers), and 
one with colitis and one was a case in a patient that was receiving a diagnostic test 
(ultrasound). Sub-cluster II-e contained 3 cases, 2 from 2011 and 1 from 2012, the 
patients were adults with colic complaint. The last sub-cluster is the II-f and contained 9 
cases: 7 from adults, 1 from a foal and one without reported age. Four cases presented 
with colic, one with chronic diarrhea, one with a mass in the stomach and 3 with general 
signs. From these cases, one strain was resistant to sulfisoxazole; one strain was resistant 
to streptomycin and sulfisoxazole; and one harbored and exhibited MDR to 7 
antimicrobials (with 16 antimicrobial resistance genes detected). Detailed information of 
the cases per each cluster is shown in Table 7.  
 
Geographical location of the phylogenetic clusters 
 The cases in the clusters were roughly geo-located by GPS coordinates (so as to 
protect the identity of the owner by zip code) into a map to find common locations and 
potential outbreaks. Via mapping it was noticed that Salmonella Anatum and S. 
Braenderup presented some grouping of cases in the same location as we saw in the 
phylogenetic analysis (Figure 39). 
 Salmonella Anatum had 4 cases came from the same location. In general, the 
cases of Anatum were grouped by location (Figure 40). Furthermore, Salmonella 
Braenderup had 6 cases associated with the same source (Figure 41). In contrast, the 
cases of S. Newport were very scattered as can be seen in the map (Figure 42).    
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Table 7. Equine cases of genetically related Salmonella Newport from Cluster I and II by phylogeny. 
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I I-a 10-083 American Paint 8/27/2011 9/3/2011 Adult colic Pansusceptible
I I-a 11-049 Quarter Horse 10/7/2012 10/8/2012 Adult diarrhea Pansusceptible
I I-b 08-021 Miniature Donkey 7/11/2007 7/11/2007 NR colic Pansusceptible
I I-b 09-022 Quarter Horse 8/16/2008 8/19/2008 NR colitis Pansusceptible
I I-b 09-035 Mixed Breed 11/16/2008 11/19/2008 Adult colic Pansusceptible
I I-b 09-079 American Miniature 5/8/2009 5/8/2009 Adult colic Pansusceptible
I I-b 10-029 Gypsy Vanner 9/27/2010 10/7/2010 Foal diarrhea Pansusceptible
I I-b 11-052 Quarter Horse 10/12/2012 10/31/2012 Adult fever Pansusceptible
I I-b 11-068 Thoroughbred 1/18/2013 1/26/2013 Senior colic Pansusceptible
I I-b 12-025 Quarter Horse 4/19/2014 4/25/2014 Foal decreased suckle reflex, lame in front legs Pansusceptible
II II-a 08-026 Quarter Horse 8/8/2007 8/15/2007 NR Intermitent diarrhea, now drawn up, weight loss Pansusceptible
II II-a 09-057 Mixed Breed 2/26/2009 3/12/2009 Adult fever, possible fluid in lungs Pansusceptible
II II-b 10-035 Quarter Horse 11/15/2010 11/22/2010 Foal colic Pansusceptible
II II-b 10-049 Quarter Horse 1/14/2011 2/3/2011 Adult possible choke Pansusceptible
II II-c 08-041 Andalusian 12/6/2007 12/14/2007 NR toxic insult to liver-enzymes up, colic Pansusceptible
II II-c 12-023 Quarter Horse 4/9/2014 4/9/2014 Adult colic Pansusceptible
II II-d 08-047 Quarter Horse 12/28/2007 12/28/2007 NR colic Pansusceptible
II II-d 09-017 Clydesdale 8/13/2008 8/17/2008 Adult colitis Pansusceptible
II II-d 09-023 Quarter Horse 8/16/2008 8/25/2008 Adult colic Pansusceptible
II II-d 09-042 American Paint 12/30/2008 1/13/2009 Adult colic Pansusceptible
II II-d 10-011 Spanish Barb 12/12/2009 12/16/2009 Adult colic Pansusceptible
II II-d 11-095 Arabian 9/25/2013 9/27/2013 Adult stomach ulcers, colic Pansusceptible
II II-d 12-001 Quarter Horse 9/16/2013 9/16/2013 Adult ultrasound Pansusceptible
II II-e 10-093 American Miniature 9/29/2011 9/29/2011 Adult colic Pansusceptible
II II-e 10-094 American Paint 10/11/2011 10/20/2011 Adult colic Pansusceptible
II II-e 11-045 Thoroughbred 9/24/2012 9/24/2012 Adult colic Pansusceptible
II II-f 09-007 Belgian 7/19/2008 7/21/2008 Adult fever Pansusceptible
II II-f 10-066 Quarter Horse 6/5/2011 6/12/2011 Adult mass in stomach AMP-CHL-GEN-STR-FIS-TET-SXT
II II-f 11-040 Quarter Horse 8/18/2012 8/25/2012 Adult low protein level Pansusceptible
II II-f 11-042 Thoroughbred 9/4/2012 9/21/2012 Adult colic Pansusceptible
II II-f 11-055 Foreign Warm Blood 10/29/2012 12/18/2012 Adult colic Pansusceptible
II II-f 11-083 Quarter Horse 7/18/2013 8/1/2013 Adult colic Pansusceptible
II II-f 11-092 American Miniature 9/21/2013 10/1/2013 Foal chronic diarrhea STR-FIS
II II-f 12-012 American Paint 1/26/2014 2/9/2014 Adult colic FIS
II II-f 13-016 Paso Fino 9/27/2015 9/27/2015 NR dehydration Pansusceptible
A mino glyco sides B eta- lactams
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Figure 39. Location of genetically related cases of Salmonella. The size of the circle represents the number of cases.   
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Figure 40. Location of genetically related cases of Salmonella Anatum. The size of the circle reflects the number of cases in 
each location.  
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Figure 41. Location of genetically related cases of Salmonella Braenderup. The size of the circle reflects the number of the 
cases in each location.   
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Figure 42. Location of genetically related cases of Salmonella Newport. The size of the circle reflects the number of cases.
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CHAPTER IV 
DISCUSSION 
 
Evaluation of the proportional morbidity attributed to each Salmonella enterica 
serotype 
Monitoring changes in the trends of prevalence of Salmonella in horses is useful 
for identification of possible nosocomial or other common-source outbreaks, and to 
improve the knowledge in diagnosis, treatment and epidemiology of the disease (8). 
Although Salmonella is often found as an asymptomatically shed organism in the feces 
of horses, some factors like age, immune system status and serotype can result in high 
morbidity and even mortality in this species. Although there have been studies published 
on specific Salmonella outbreaks in equine hospitals (10), and some studies on clinical 
cases in the northeastern United States, to our knowledge there are no published studies 
on the proportional morbidity of Salmonella cases in horses in the southern United 
States. This area of the United States is of major importance to the equine community. 
As one example, Texas has the highest population of horses (978,822) in the U.S. (96). 
The present study analyzed Salmonella enterica recovered from 255 samples collected 
over a 9-year period (2007-2015) among horses admitted to an equine referral hospital 
located in the southern region of the U.S. This study was unable to estimate the 
prevalence of Salmonella in asymptomatic horses, nor to estimate the incidence of 
salmonellosis in the equine population. However, among admitted cases with a 
differential diagnosis of salmonellosis and a confirmed isolate of Salmonella enterica, 
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we have been able to establish the proportional morbidity attributed to each serotype and 
explore aspects of the resistance phenotype, plasmid profiles, and phylogenetic 
relatedness of strains of the same serotype. In doing so, we are able to explore the 
relative frequency of potential field versus hospital outbreaks versus random cases 
admitted to the hospital. 
The breeds of the horses in this study reflected reasonably well the demographic 
population in the United States, with Quarter Horses representing the highest number of 
horses (3,288,203) followed by Thoroughbreds (1,291,807) (96), as reported in similar 
studies (50). The mean age of the patients was 7 years and was similarly reported in 
other studies of horses with Salmonella (50).  
Findings in this study demonstrate that the signs of colic and diarrhea were 
associated with patients with diagnostic of salmonellosis. Studies have shown that horses 
with colic are more susceptible to acquiring and shedding Salmonella, compared with 
other hospitalized equine patients (97); in addition, colic can be a presenting sign of 
colitis. Diarrhea is considered a traditional sign of salmonellosis (50). The syndrome 
“toxic enterocolitis” is characterized by fulminant diarrhea, between 2 or 3 days after 
inoculation (98). In this research, general signs (fever, dehydration, loss of weight, and 
anorexia, between others) were more often associated with juvenile horses; these signs 
are part of a milder GI syndrome that can develop in the first week post-inoculation once 
the horses start rapid fecal shedding; however, it can also be associated with toxic 
enterocolitis syndrome (8). Peracute sepsis can occur with general symptoms, where the 
most common complications are the ileus and gastric dilation with this syndrome usually 
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being fatal (8). Studies in Florida (U.S.) associated younger horses with risk factors like 
undergoing surgery, or remaining in larger groups (herds) with the increased risk of 
exposure to pathogens when compared with solitary individuals (99). In our study, 
symptoms as diarrhea was associated with foals and colic was associated with adults; 
this was expected, especially because diarrhea is the most common sign of salmonellosis 
and colic is associated with shedding of Salmonella. Diarrhea in foals is the second most 
common symptom of salmonellosis and specifically chronic diarrhea in foals is the third 
most common following after an acute episode (23). Chronic diarrhea can have a poor 
prognosis if there is no improvement within 4 to 6 weeks (17). The musculoskeletal 
signs (bone infections, fetlock problems, and swollen joints) were more often associated 
with foals in our dataset, suggesting that these animals may have been developing 
septicemia and consequently developing osteomyelitis (22).      
The American Paint breed, when infected with Salmonella, was more often 
associated with presenting signs of colic; more generally, other studies have reported 
that Thoroughbred horses are more likely to exhibit colic (not Salmonella specific) than 
Quarter Horse, Paint, or Appaloosa breeds (14). There are other studies that 
demonstrated that breed is not a risk factor for salmonellosis (100).  The respiratory 
signs possible as a first cause of admission to the hospital was more associated with 
mixed breed than with others breeds in the study maybe due to few cases reported with 
these symptoms.  
Identification of Salmonella serotypes helps to focus Salmonella outbreak 
investigations and track them to their sources (e.g., food, environment, human, animals) 
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(101). Increment of cases of a specific serotype might make infection control officers 
suspicious of a potential outbreak. The classification of isolates into serotypes is mainly 
accomplished using the White-Kauffmann-Le Minor (WKL) scheme. However, with 
advancements in whole genome sequencing (WGS), and improved bioinformatics tools 
great advances have taken place to help determine pathogen relatedness and also to 
generate information about the characteristics of the organisms (e.g., serotype, virulence, 
antimicrobial susceptibility) (102).  
Results showed that serotyping and SeqSero (in silico Salmonella serotype 
prediction) were very consisting, founding difference between both techniques in only 
4% (10 strains). In this study, the most common among the 46 different Salmonella 
serotypes was Newport, as also described by others (31, 48); furthermore, S. Newport 
remains one of the most frequently identified serotypes in humans in the U.S. (103). In 
another study by Vetro (2004), among clinical cases in horses the second most common 
Salmonella serotype was Newport (11%) (99). In our study, the second most prevalent 
serotype was S. Anatum, followed by S. Braenderup, S. Infantis, S. Javiana and S. 
Typhimurium; these findings agree with the most frequent serotypes in horses (8). 
Although S. Braenderup was found among the main 16 serotypes in a study with 106 
cases of salmonellosis, in horses in Florida at a veterinary teaching hospital (99), and is 
one of the 10 most common serotypes among human cases in the U.S, it has generally 
been reported in low percentages (<1%) in other animals (104). 
There was a significant association between S. Braenderup and the likelihood of 
presentation as a subclinical presence of salmonellosis. This finding could be explained 
 83 
 
by the fact that S. Braenderup in horses is an unrestricted (UR) serotype, often without 
presence of severe clinical signs. Nevertheless, this finding indicates the potential risk of 
zoonotic transmission to humans in contact with the asymptomatic infected horses (105). 
In this study, S. Typhimurium was associated with enteric disease and it is known that S. 
Typhimurium can be highly pathogenic in horses (106). It is also classified as a UR 
serotype with the ability to invade many different hosts (105). S. Typhimurium was also 
associated with musculoskeletal signs in our study, which agreed with Platt who found 
that S. Typhimurium was associated with septicemia and consequently osteomyelitis 
(107). This could be another potential risk factor to develop an outbreak with these UR 
serotypes in hospitals, due to the fact that horses with exhibiting signs of colic usually 
are not placed in isolation (50). In the hospital from which the isolates in this study were 
collected, the standard practice is to isolate horses with diarrhea or horses with three or 
more clinical signs consistent with salmonellosis (that is, other than diarrhea but 
including also fever and neutropenia). The presence of Salmonella Rubislaw could be 
due to possible source of contaminated surface waters as was reported in a previous 
study (108, 109).   
In an study in 2010, the Arabian breed was found as one of the best predictors of 
Salmonella shedding in horses with acute colic and lacking typical salmonellosis signs 
(50); however, there have been no studies published that are appropriate for predicting of 
Salmonella shedding for specific serotypes or by breed (including ours, since we start 
with 100% of cases harboring Salmonella). In our study, salmonellosis in Arabian horses 
was associated with S. Infantis and S. Javiana and those serotypes are reported as being 
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the most frequent in clinical cases in horses (8). Salmonella Braenderup was more often 
associated with Thoroughbred horses. There are few reports of S. Braenderup clinical 
cases in horses, nor association with horse breeds, and the reason of the unreported 
presence of this serotype could be due to its subclinical presence; however, S. 
Braenderup has been commonly reported in beef cattle (110) and horses that are co-
located with beef cattle on pastures or in dry lots might be at risk of exposure to this 
serotype. Two of the most prevalent serotypes in our study (S. Typhimurium and S. 
Braenderup) were significantly associated with increased risk of isolation from foals and 
adults.  
Seasonality is an important variable to evaluate with the prevalence of 
Salmonella serotypes because some studies reported association between seasonality 
with higher incidence of salmonellosis in hospitalized horses (13). In our research, 
Salmonella Braenderup (typically, subclinical) was present at the beginning of the spring 
season of 2008, and then S. Newport was more detected in the middle of the summer 
until the end of 2008; this may be consistent, knowing that the summer season has been 
associated with high shedding of Salmonella in horses (13, 27). One reason is that as 
enteric bacteria Salmonella are better able to multiply at higher ambient temperatures 
with inter-generational times of 20 minutes, and the growth rate increases even further at 
30°C and above (111). In our study, S. Braenderup was present in the spring of year 
2009 similar to 2008. In 2010, S. Braenderup was presented in spring and also in fall 
season; one hypothesis for this observation could be that there is more contamination 
with flies in this season (112), or increased agricultural activities. Perhaps counter-
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intuitively, cooler wet weather can contribute to the survival of the organism for long 
periods of time (113). S. Newport was present in the summer of 2010 until the end of the 
year, similar to 2008. S. Newport was present from spring to fall in 2013. In 2014, S. 
Newport was present from the beginning of the year until spring. However, the trends 
changed in 2015, where S. Anatum exhibited the highest proportional prevalence from 
spring to summer seasons. These results demonstrate high variability of the seasonality 
of serotypes and the finding of specific serotypes throughout the year.    
Although many of the serotypes of Salmonella enterica subspecies enterica may 
not have plasmids, plasmids are often associated with those serotypes that cause clinical 
disease in humans and farm animals (e.g., Abortusovis, Cholerasuis, Dublin, Gallinarum, 
Pullorum and Typhimurium) (77). These strains usually have specific virulence 
plasmids, but also can harbor plasmids that more generally can transfer resistance to 
antimicrobials.  
In our study, plasmid incompatibility replicon type IncI was the most frequently 
identified plasmid and this agrees with previous findings concerning Salmonella (77). 
IncI1 was the predominant plasmid especially in Salmonella Anatum. IncI1 has been 
recognized for harboring antimicrobial resistance genes, particularly ESBLs (114, 115). 
Our study showed the highest presence of plasmid IncF present in the main serotypes: S. 
Anatum, S. Typhimurium, S. Newport and S. Braenderup. The IncF plasmid is very 
common in Salmonella isolates, usually carrying beta-lactamases and acc(6’)-lb-cr 
genes. On the other hand, this family also is very common in the intestinal flora of 
humans and animals, even so without the presence of antimicrobial resistance genes 
 86 
 
(116). The IncHI plasmid type was present mainly in S. Anatum and S. Newport. The 
IncCOL plasmid was mainly detected in Salmonella Anatum and Newport. Bacteria use 
this plasmid to produce bactericidal proteins known as colicins which help to kill (or, 
suppress) other competing bacteria. Furthermore, they are frequently competent for 
plasmid transfer (117). The IncA/C2 plasmid type was detected in low frequency in all 
the serotypes, and was more often detected in S. Typhimurium and S. Rubislaw. This 
plasmid has been related with the sul2-containing resistance island ARI-B (118). As well 
it is a helper in the mobilization of the Salmonella Genomic Island 1 (SGI1) family that 
contains integrative mobilizable elements that contain different combinations of AMR 
(Antimicrobial Resistance) in a complex class 1 integron to recipients that lack SGI1 
(119). Salmonella Newport harbors the X plasmid type, which has been associated with 
some of the most relevant and dispersed resistance genes (blaNDM-1, blaKPC-2 and blaCTX-
M-15) (87). IncQ in S. Anatum and S. Newport, has been associated with strA, strB and 
sul2 genes in E. coli (87). Further characterization is necessary to evaluate the specific 
genes in the corresponding plasmids and that information would be indispensable to 
improving the epidemiologic surveillance in Salmonella strains, in addition to tracing the 
spread and evolution of the antimicrobial resistance.   
 
Evaluation of antimicrobial resistance patterns of isolated Salmonella from horses 
admitted to an equine referral hospital in the southern United States 
Increasingly resistant bacterial isolates can generate high rates of morbidity and 
mortality that consequently increase costs to the human and animal health systems due to 
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failure of treatments, extended disease duration, additional diagnostic tests, and the use 
of more expensive drugs (120).  
Although there are a lot of government institutions working on programs of 
surveillance for antimicrobial resistance (CIPARS, ESVAC, DANMAP, MARAN, 
GermVet, ITAVARM), there are few that provide antimicrobial resistance surveillance 
in horses (121).  It has been shown that antimicrobial resistant bacteria could be 
transferred between horses and humans (122). For this reason, it is imperative to identify 
sources of Salmonella and antimicrobial resistance transmission where humans and 
horses come into contact (such as referral hospitals),  to subsequently give guidelines for 
the correct use of antimicrobials, and to measure the potential risks to public health (48).  
The present study analyzed data over a 9 year period (2007-2015) including 255 
Salmonella isolated from patients of an equine referral hospital in the southern United 
States. All isolates were tested for antimicrobial susceptibility to each of the 14 
antimicrobials according to National Antimicrobial Resistance Monitoring System 
(NARMS) guidelines. Furthermore, each isolate was analyzed using whole genome 
sequencing (WGS) for detection of antimicrobial resistance genes (ARG). The use of 
WGS will help to enhance our knowledge on ARG circulating in Salmonella from horses 
and their environment. In addition this information, such knowledge can help to identify 
resistance hazards and will improve control strategies to mitigate the risks (123). In 
general, it was found that most of the Salmonella isolates were pan-susceptible to all 14 
antimicrobials; however, they were more often resistant to sulfisoxazole 10.59% (27), 
ampicillin 9.8% (25) and tetracycline 9.8% (25) than to newer classes of antimicrobials. 
 88 
 
These results are somewhat consistent in that the most common antimicrobials used in 
horses in the United States are gentamicin, potentiated sulfonamides and doxycycline 
(124).  
 In a recent study in Salmonella from horses at w University Hospital, it was 
found that the isolates were more resistant to amoxicillin-clavulanic acid, ampicillin, 
cefazolin, cefoxitin, ceftiofur, chloramphenicol and tetracycline than to other classes 
(48). Similar results had been reported in a study in Netherlands with 232 Salmonella 
from horses with resistance to tetracycline (53%) and ampicillin (34%) (125). 
Salmonella recovered from horse diagnostic samples at four state veterinary diagnostic 
laboratories (AZ, MO, NC, and TN) had higher resistance to ampicillin, 
chloramphenicol and sulfamethoxazole (126).  
The resistant Salmonella were multidrug resistant (MDR: resistant to greater than 
two classes of antimicrobial) in 10.2% of isolates. These MDR Salmonella usually were 
harboring plasmids that could confer resistance to multiple antimicrobials, and 
furthermore many could have multidrug efflux pumps (127). Our results showed that the 
prevalence of resistant Salmonella was variable among the 12 different resistant 
serotypes. The most resistant serotype with 8 different resistance patterns and 5 MDR 
strains was S. Anatum, followed by S. Rubislaw and then S. Braenderup. Different 
results were reported by Cummings in 2016, where the most resistant serotypes were S. 
Newport, S. Oranienburg and S. Typhimurium (48). The most resistant serotypes in 
horses at a hospital in Florida (U.S.), were S. Java, Typhimurium var. Copenhagen, 
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Javiana and Newport (99). In a study of horses in the Netherlands (2002) the most 
resistant serotype was S. Typhimurium (125).  
Although laboratory-based, phenotype criteria still dominate the epidemiology of 
antimicrobial resistance, new genome scale tools are becoming a routine part of the 
laboratory analysis (128). Whole genome sequencing (WGS) can help to improve the 
comparison among isolates, allowing evaluation of different antimicrobials at the same 
time and possibly refining interpretative criteria, however, there are still some issues to 
consider as the requirements needed of minimum sequence data quality standards and 
good understanding of the genetic context to make interpretations (123).  
We found that most of the Salmonella isolates carried at least one antimicrobial 
resistance gene (per ResFinder), including more specifically two aminoglycoside genes: 
aac (6’)-Iaa and aac (6’)-Iy, however those genes have reached their limit of evolution. 
Those genes no longer appear to encode resistance to aminoglycosides, consistent with 
the small evolution of AAC(6’) proteins (129). The retention of the aac(6′)-Iy gene 
evolution suggests a potential cellular function that differ from aminoglycoside 
resistance. Studies have suggested that the usefulness of this gene is production of 
enzymes involved in carbohydrate transport or metabolism endogenous and specific to 
Salmonella (130).  
In general, our results show that acquired phenotypic resistance in Salmonella 
presented almost perfect agreement with the presence of known antimicrobial resistance 
genes. High congruence was present between MICs (especially above the clinical 
breakpoint) and the presence of known resistance genes, with agreement in 96% of 
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cases. There were discrepancies between phenotypic and genotypic interpretations for 
some antimicrobials; mainly, quinolones, aminoglycosides, and tetracyclines.  
Nalidixic acid and ciprofloxacin were the representative quinolones tested. There 
were 3 isolates that had a resistant (R) phenotype to nalidixic acid but a susceptible (S) 
genotype. A similar situation was detected in 2 isolates with an R phenotype to 
ciprofloxacin but an S genotype. For these isolates one hypothesis could be that the 
phenotypic resistance to these quinolones was conferred by a DNA topoisomerase 
mutation and was not generated by qnrB2 or aac (6’)-lb-cr genes and that could not be 
detected by the analysis through the Resfinder tool; that is, because this web server only 
curates horizontally acquired resistance genes and does not include resistance mediated 
by single- or double-stage mutations of genes (131). There were four Salmonella with an 
R genotype to nalidixic acid but an S phenotype; however, the same isolates had a 
ciprofloxacin R genotype presenting moderate agreement using ciprofloxacin 
intermediate MICs (0.12 to 0.25 ul/ml). Isolates with Plasmid-Mediated Quinolone 
Resistance (PMQR) (e.g., qnrB) do not usually show clinical resistance to ciprofloxacin 
or nalidixic acid, unless Quinolone Resistance-Determining Regions (QRDR) mutations 
or additional PMQR genes are present (123).  
It was previously reported that an E. coli form a clinical case was resistant to 
ciprofloxacin, but susceptible to nalidixic acid. The authors demonstrated that at least 
one of two mechanisms of resistance were present: 1) decrease of the OM (Outer 
membrane) permeability or 2) alteration of the DNA gyrase (132). The results in 
ciprofloxacin illustrate that WGS is a very efficient tool to detect decreased 
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susceptibility to some antimicrobials. It is suggested that fluoroquinolones are the 
antimicrobials of choice to treat salmonellosis in adult humans because these 
antimicrobials are lipid soluble and Salmonella are facultative intracellular pathogens. 
Oral use of ciprofloxacin is not recommended in horses because it can cause colitis and 
it is not recommended to use in foals because it affects cartilage development, similar to 
children (133). This antimicrobial is included on the list of critically important 
antimicrobials for humans (134); therefore, its use should be restricted to cases that have 
few other options for treatment. 
Tetracyclines is consider highly important antimicrobial for human medicine 
(135). Tetracycline resistance genes (tet(A), tet(B), tet(C), tet(D) and tet(E)) were 
present in Salmonella. One study in E. coli from non-clinical horses samples found 
tet(A), tet(B), and tet(C) genes in the bacteria (136). The common tetracycline genes 
reported for Salmonella are tet(A), tet(B), tet(C), tet(D) and tet(G). On the other hand, 
tet(E) was previously reported in Aeromonas, Providencia, Pseudomonas, Serratia, and 
Vibrio (76) and often present in aquatic environments (137). The tet(E) gene also has 
been detected in LFE (lactose-fermenting Enterobacteriacea) isolated from sewage 
treatment plants in the United States and China (138).  
Tetracycline also presented some discrepancies: 7 isolates had an R phenotype 
with an S genotype and 3 isolates with an R genotype harbored an S phenotype. Previous 
work has suggested that this phenomenon could be due to low antimicrobial use that can 
result in carriage of tetracycline resistance pseudogenes that remain phenotypically 
susceptible when compared with high antimicrobial use (139). The genotype resistant 
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isolates that were phenotypically susceptible may harbor pseudogenes. Pseudogenes are 
coding sequences that have lost their ability to be expressed because they have been 
inactivated by mutations, including non-sense substitutions and frame-shifts, truncation 
by deletion, or else rearrangements (140). However, more work is needed to determine 
whether these mutations prevent gene expression (139). To confirm this hypothesis, it 
would be necessary to correlate the use of antimicrobials with the phenotypic and 
genotype antimicrobial profiles of the bacteria. Another explanation for the R phenotype 
and S genotype isolates could be that it could well be an unidentified resistance 
mechanism in the genome. Those disagreements should disappear with the discovery of 
new antimicrobial resistance mechanism and repeated in silico analyses (123). 
In our study, beta-lactamase genes (blaTEM-1B), plasmid mediated mobilized 
AmpC genes (blaCMY-2) and extended-spectrum beta-lactamases (ESBLs) (blaSHV-12 and 
blaCTX-M-27) genes were found, with good agreement with phenotypic susceptibility. 
When blaTEM-1B was found in the presence of an ESBL, the latter phenotype dominated, 
conferring resistance to third generation cephalosporins that would otherwise not be 
seen. The presence of these plasmid-borne genes in Salmonella from equine patients at a 
referral hospital is alarming because these genes can be transmitted easily to other 
bacteria and distributed to other animals and to humans. Although some years ago ESBL 
genes were quite rare among Salmonella from human infections in the United States 
(141), a recent surveillance in all 50 states and the District of Columbia found in 
nontyphoidal Salmonella numerous ESBLs, containing blaSHV-12, blaSHV-30, blaCTX-M-1, 
blaCTX-M-55 and two blaCTX-M-6  genes (142). 
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An outbreak associated with Salmonella Newport MDR-AmpC at another 
veterinary teaching hospital involved a high case fatality in hospital patients due to 
failures in the ICP (Infection Control Program) (50). In 2003, an ESBL-producing S. 
enterica serotype Newport MDR-AmpC with blaTEM-1b and blaSHV-12 genes from an 
outbreak in equines was reported for the first time and led to the closure of a veterinary 
teaching hospital for 3 months (143). Interestingly, in our study almost all of the isolates 
of Salmonella with blaSHV-12 (an ESBL) contained the blaTEM-1b gene as well. Carriage of 
beta-lactamase resistance in these isolates is not restricted to the United States. In 
Argentine in 2010, there was a reported case of infection with ESBL-producing 
Salmonella Typhimurium with blaCMY-2 gene in a race horse with diarrhea (144). In a 
retrospective study in Germany blaCTX-M-₁₅ was detected in E. coli and Salmonella from 
animals, and blaCTX-M-₁₅ was detected in Salmonella Typhimurium (145). The presence 
of ARG may result in failure of the treatment for salmonellosis, especially in foals. In 
foals, it is recommended to use extended-spectrum cephalosporins or ampicillin-
sulbactam, alone or in combination with an aminoglycoside (gentamycin or 
streptomycin) (133). In this study, we found resistance to ampicillin and potentiated 
amoxicillin (clavulanic acid) with the presence of beta-lactamase genes; these findings 
have important implications as the presence of these genes may be associated with 
treatment failure. 
 Presence of aminoglycoside resistance genes in Salmonella from horses has been 
previously reported. Similar to other studies, we found aadA1, aadA2, producing 
resistance to streptomycin (126), and aadA7, strA and strB were also detected. Presence 
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of gentamicin resistance genes (aac(3’)-IId, aac(3’)-VIa, rmtE, aac(6')-IIc, aph(3')-Ia 
and aph(3')-Ic) were detected in Salmonella. These results are important because 
aminoglycosides are categorized as critically important for use in horses (146). 
Aminoglycosides are used to treat septicemia, and different digestive, respiratory and 
urinary diseases. Moreover, aminoglycosides are critical to treat infections with 
Pseudomonas aeruginosa. Enterobacteriaceae and Pseudomonas spp. can share AMR 
genes (147).   
Genes producing resistance to sulfonamides (sul1 and sul2) and 
trimethoprim/sulfas (dfrA) were found. Zhao, et al. reported presence of dfrA1 in 
Salmonella Anatum from horses (126). Meanwhile, S. Typhimurium recovered from 
clinical cases in Netherlands carried dfrA1, dfrA or dfrA14 (148). Sulfonamides are also 
on the list of medically important antimicrobials in animals and human (149). This 
family of antimicrobials are used to treat bacterial, coccidial, and protozoal infections 
(146).  
Chloramphenicol resistance was present in Salmonella. This finding agrees with 
Cummings et al. who found chloramphenicol resistance at 51.5% in their isolates (48). 
In our study, phenicol resistance phenotype and genotype exhibited the highest 
agreement (98.8%). The presence of phenicol resistance genes (catA2, floR and cmlA1) 
was detected. The cat gene, responsible for enzymatic resistance, was the predominant 
phenicol resistance gene among our isolates. These data support that chloramphenicol 
acetyltransferases are often the cause of resistance to chloramphenicol as reported by 
others (150). The floR gene is a common genetic determinant responsible for florfenicol 
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resistance in Gram-negative bacteria, including E. coli from animals (Cloeckaert, 
Baucheron et al. 2000). Phenicol resistance was reported in Salmonella Typhimurium 
DT104 from a clinical horse case with the floR gene associated with SGI1 (Salmonella 
Genomic Island 1) (148).    
In this study, Salmonella occasionally carried mphA and ere(A). The mphA gene 
has been associated with resistance to azithromycin among E.coli and Shigella (151), 
while ere(A) has been reported in Citrobacter, Enterobacter, Escherichia, Klebsiella, 
Pantoeae, Pseudomonas, Proteus, Serratia, Stenotrophomonas, Vibrio and 
Staphylococcus (152). In horses, macrolides are not used in the treatment of Salmonella 
because they can induce acute colitis by disruption of the microflora (153, 154), and 
although macrolides are not currently used commonly to treat non-typhoidal Salmonella, 
the presence of these genes may generate major public health consequences because E. 
coli, Shigella and Salmonella Typhi can exchange plasmids (151).   
Antimicrobial therapy for Salmonella in horses generally should be restricted to 
cases of septicemia and osteomyelitis, and other severe extra-intestinal involvement 
(155). Antimicrobial therapy may cause persistence of the bacteria in the intestine 
following recovery and prolonged shedding of the organism. Also, antimicrobial therapy 
may increase resistance among commensal bacteria and lead to the overgrowth of 
toxigenic bacteria such as Clostridium difficile. It is important to emphasize that 
antimicrobial treatment must ideally be established according to the results of the 
antimicrobial susceptibility of the specific isolate; or in cases that require immediate 
intervention to prevent death, it is possible to use the historic antimicrobial susceptibility 
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records at the hospital, farm or geographic region to improve so-called empirical therapy 
(8).   
 
Phylogenetic analysis 
Improvement and new capabilities in sequencing technologies have allowed for 
new applications in clinical microbiology and epidemiology. Decreasing the cost of 
sequencing may allow for WGS to be the new standard for bacterial strain typing and 
allow for improved epidemiological investigation of outbreaks. Molecular epidemiology 
based on WGS is developing rapidly. Before the WGS era, pulse-field gel 
electrophoresis (PFGE) was the gold standard for epidemiological investigations (156). 
However, PFGE cannot separate high closely related strains because that difference does 
not have effect in the electrophoretic mobility of a restriction fragment (157). Usually, 
outbreak isolates have very little diversity and require extensive genomic methods to 
differentiate and categorize the isolates (158). There are currently two methods to 
analyze the phylogeny: 1) core genome SNP based analysis, and 2) MLST based on 
whole genomes, pangenomes, or core genomes. Core genome SNP analysis is more 
sensitive for discrimination of very closely related isolates to a level not previously 
achievable by sub-genomic typing tools (e.g., PCR-based MLST and PFGE) because of 
their limited resolution (159).  
SNP-based comparison methods are effective to analyze genomes with low 
numbers of SNPs and inversions, insertions, and deletions, and can be used to trace 
evolutionary processes during extended outbreaks (91).   
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 To the best of our knowledge, ours is a pioneering study using WGS to analyze 
Salmonella genomes from clinical cases of horses from a referral hospital over an 
extended period of time. Phylogenetic analysis of the presumptively epidemiologically 
related Salmonella Anatum, Salmonella Braenderup, and Salmonella Newport isolates 
were conducted. 
 
Salmonella Anatum    
Two cases in Sub-cluster I-c from 2008 were very closely related with 
differences in four SNPs; one had 12 resistant genes with 7 different plasmids detected, 
while the other presented 13 resistant genes with 2 plasmids. Both MDR cases arose 
from different farm locations; however, they arrived at the hospital in the same month. 
This results are suggestive of a potential common source in the hospital. Four cases out 
of five in Sub-cluster I-d from 2015, came from the same farm; 2 of them carried tetB 
genes. These results suggested that these horses were coming to the hospital with the 
infection. In Sub-cluster II-b, the 3 cases from 2009 came from different farms, further 
suggesting a possible nosocomial transmission.   
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These finding reinforce that it is necessary to implement measures to control the 
spread of these MDR Salmonella. Deeper research is needed to explore possible 
outbreaks in the hospital and identify common sources of this specific serotype. 
 
Salmonella Braenderup   
Between the period of March and April of 2008, four identical genomes from 
Sub-cluster I-e of MDR S. Braenderup (i.e., resistant to 8 antimicrobials) and with the 
same three resistant genes (rmtE, blaCMY-2 and sul1) that could be transmitted by the same 
plasmid replicon type (I1) suggest a possible outbreak at the hospital. An acknowledged 
outbreak of S. Braenderup in 2009 was confirmed by phylogenetic analysis in our study. 
This outbreak included mares (2) and their foals (4) coming from the same external 
facility. From Sub-cluster I-b in 2010, an MDR S. Braenderup was isolated from a foal 
that was genetically closely related to a pansusceptible isolate. Moreover, an unusual 
ESBL gene (blaCTX-27) was present in this MDR strain and likely carried on an IncI1 
plasmid. These two cases both came from a mare and its foal. These findings could point 
to acquisition of the plasmid either from the flora of the dam or another common 
environmental source.    
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Salmonella Newport  
In 2008, Sub-cluster II-d included three closely genetically related cases; 
however, there was not enough information to associate with the origin of the outbreak. 
In 2011, Sub-cluster II-e presented cases closely related between September and October 
and while it seems possible that those cases were coming from the same location, we did 
not have information available to confirm.  
In general, Salmonella Newport in our study were very susceptible to the 
antimicrobials; however, some strains belong to Sub-cluster II-f across different years 
were resistant – one of them was MDR with 8 resistant genes detected (aac(6’)-lb-cr, 
aac(6’)-IIc, aph(3’)-Ia, strA, strB, blaSHV-12, blaTEM-1B, ere(A), mphA1, dfrA15 and sul1) 
carried on 4 plasmids (FIA, H1, 12 and Q). In general, the closely related Salmonella 
genomes did not come from the same ranch; however, it is necessary to research more 
about possible common sources of this frequent and widely dispersed (geographically 
and temporally) serotype.       
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CHAPTER V  
CONCLUSIONS 
   
This study enhances our understanding of Salmonella epidemiology among 
horses admitted to referral hospitals with a differential diagnosis of salmonellosis. Our 
analysis provides a contextual framework necessary to make conclusions regarding 
likely infective sources of Salmonella in horses presenting to the hospital and potential 
action plans to prevent and control the dissemination of the bacteria. The pursuit of 
mitigation strategies include: improved communication, isolation of animals, restriction 
of contact with suspicious animals (including emphasis on routine hygiene following 
animal contact), restriction of movements inside the hospital, improvement of the use of 
protective equipment for personal, environmental and animal sampling, and thorough 
cleaning and disinfection are some of the most important biosecurity strategies to avoid 
future outbreaks at a veterinary referral hospital. Biosecurity measures are recommended 
also at the level farm as many of these outbreaks clearly trace back to a common farm 
source. 
Horses shedding antimicrobial-resistant Salmonella remain a potential hazard to 
public health. Easy dispersion and a short period of incubation of Salmonella, the 
presence of asymptomatic horses and multiple mechanisms of resistance to 
antimicrobials increase the risk of acquiring the bacteria and the potential failure of 
antimicrobial treatments in humans. Antimicrobial resistance genes can limit the 
potential treatment of salmonellosis, especially in cases where the use of antimicrobials 
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(e.g., septicemic cases) is essential. In cases where antimicrobial treatment is 
recommended, individual bacteriological and antimicrobial susceptibility testing remains 
clinically relevant, especially in guiding therapy. Minimizing and optimizing the 
antimicrobial therapy in horses can be achieved by developing and following judicious 
use guidelines. Continued monitoring of antimicrobial resistance can be used to guide 
recommendations for antimicrobial use in veterinary medicine (including stewardship 
programs) and assessing the potential risks to human. Whole genome sequencing (WGS) 
can be valuable in discriminating between closely related isolates when suspecting an 
outbreak and for monitoring persistence of a particular strain within the hospital 
environment. WGS is helpful in the investigation and monitoring of trends over time of 
the antimicrobial resistance genes, continued submission of complete genome sequences 
to globally representative whole genome databases (e.g., NCBI) will improve 
comparisons and detection of outbreaks across hospitals and region. Continued 
development of robust genomics and bioinformatics capabilities is necessary to rapidly 
generate genomics–based data that can be useful to detect, prevent and control the 
dispersion of pathogenic microorganisms and their antimicrobial resistance.   
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